MATK
Normalized values from positional scanning peptide array
Phospho-serine (pS) is a duplicate of phospho-tyrosine (pT) in PSPA
Position-wise Probabilities
Log-Odds: Probabilities / STY Background
Sites with acceptor types representing >8% and count ≥10 are included
S Sites Probabilities
T Sites Probabilities
Y Sites Probabilities
Log-Odds: S Sites / S Background
Log-Odds: T Sites / T Background
Log-Odds: Y Sites / Y Background
Sites with acceptor types representing >8% and count ≥10 are included
Motif clusters with count ≥ 10 are shown
Download
| substrate_uniprot | site | source | substrate_genes | site_seq |
|---|---|---|---|---|
| A0A2R8Y4L2 | S95 | Sugiyama | HNRNPA1L3 HNRNPA1P48 | RPHKVDGRVVEPKRAVSREDsQRPDAHLTVKKIFVGGIKED |
| A0MZ66 | Y24 | Sugiyama | SHTN1 KIAA1598 | sDEEKQLQLITsLKEQAIGEyEDLRAENQKTKEKCDKIRQE |
| A5A3E0 | Y1062 | Sugiyama | POTEF A26C1B | GGSILASLSTFQQMWISKQEyDEsGPsIVHRKCL_______ |
| A5A3E0 | Y940 | Sugiyama | POTEF A26C1B | ALDFEQEMATVAsSSSLEKsyELPDGQVItIGNERFRCPEA |
| A6NHL2 | Y319 | Sugiyama | TUBAL3 | TTACFESSNQLVKCDPRLGKyMACCLLyRGDVVPKEVNAAI |
| B2RPK0 | S15 | Sugiyama | HMGB1P1 HMG1L1 HMGB1L1 | ______MGKGDPKKPRGKMssyAFFVQtCREEHKKKHSDAS |
| O00116 | Y645 | Sugiyama | AGPS AAG5 | QWLKESIsDVGFGMLKSVKEyVDPNNIFGNRNLL_______ |
| O00165 | S153 | Sugiyama | HAX1 HS1BP1 | PDSHQPRIFGGVLESDARSEsPQPAPDWGsQRPFHRFDDVW |
| O00193 | Y84 | Sugiyama | SMAP C11orf58 | TSHFRTGEEDKKINEELEsQyQQsMDsKLSGRYRRHCGLGF |
| O00299 | Y233 | Sugiyama | CLIC1 G6 NCC27 | AyAREEFAstCPDDEEIELAyEQVAKALK____________ |
| O00488 | S93 | Sugiyama | ZNF593 ZT86 | STNLKTHFRSKDHKKRLKQLsVEPysQEEAERAAGMGSYVP |
| O14602 | Y35 | Sugiyama | EIF1AY | GKNENESEKRELVFKEDGQEyAQVIKMLGNGRLEALCFDGV |
| O14910 | Y133 | Sugiyama | LIN7A MALS1 VELI1 | KTDEGLGFNVMGGKEQNsPIyIsRIIPGGVAERHGGLKRGD |
| O14950 | Y156 | Sugiyama | MYL12B MRLC2 MYLC2B | DEEVDELyREAPIDKKGNFNyIEFtRILKHGAKDKDD____ |
| O14979 | Y167 | Sugiyama | HNRNPDL HNRPDL JKTBP | DGKMFIGGLSWDTsKKDLtEyLSRFGEVVDCtIKTDPVTGR |
| O15013 | Y1307 | Sugiyama | ARHGEF10 KIAA0294 | sLsLsHGsssLEHRSEDsTIyDLLKDPVSLRSKARRAKKAK |
| O15047 | S470 | Sugiyama | SETD1A KIAA0339 KMT2F SET1 SET1A | sPEREEVRtsPRPAsPARsGsPAPEttNESVPFAQHSSLDS |
| O15067 | Y538 | Sugiyama | PFAS KIAA0361 | GAGGNGNVLKELsDPAGAIIytsRFQLGDPTLNALEIWGAE |
| O15371 | Y50 | Sugiyama | EIF3D EIF3S7 | yQPFsKGDRLGKVADWtGAtyQDKRYTNKYSSQFGGGSQYA |
| O43390 | Y136 | Sugiyama | HNRNPR HNRPR | QESTKGPDEAKIKALLERtGytLDVttGQRKYGGPPPDSVY |
| O43390 | Y376 | Sugiyama | HNRNPR HNRPR | ILEKSFSEFGKLERVKKLKDyAFVHFEDRGAAVKAMDEMNG |
| O43615 | Y201 | Sugiyama | TIMM44 MIMT44 TIM44 | QGVEsVKKEIDDsVLGQtGPyRRPQRLRKRTEFAGDKFKEE |
| O43707 | Y212 | Sugiyama | ACTN4 | WKDGLAFNALIHRHRPELIEyDKLRKDDPVTNLNNAFEVAE |
| O43707 | Y234 | Sugiyama | ACTN4 | KLRKDDPVTNLNNAFEVAEKyLDIPKMLDAEDIVNtARPDE |
| O43852 | Y106 | Sugiyama | CALU | GFVtVDELKDWIKFAQKRWIyEDVERQWKGHDLNEDGLVsW |
| O43852 | Y185 | Sugiyama | CALU | KDGDLIATKEEFtAFLHPEEyDyMKDIVVQEtMEDIDKNAD |
| O43852 | Y263 | Sugiyama | CALU | KNRDGKMDKEEtKDWILPsDyDHAEAEARHLVyEsDQNKDG |
| O43852 | Y47 | Sugiyama | CALU | RVHHEPQLsDKVHNDAQsFDyDHDAFLGAEEAKtFDQLtPE |
| O43865 | Y28 | Sugiyama | AHCYL1 DCAL IRBIT XPVKONA | PLPGVGEELKQAKEIEDAEKysFMATVTKAPKKQIQFADDM |
| O60343 | T749 | Sugiyama | TBC1D4 AS160 KIAA0603 | ENEIRQDTASESSDGEGRKRtSstCsNEsLsVGGTSVTPRR |
| O60361 | Y136 | Sugiyama | NME2P1 | SLRFKPEELVDYKSCAHDWVyE___________________ |
| O60506 | Y133 | Sugiyama | SYNCRIP HNRPQ NSAP1 | ADSSKGPDEAKIKALLERtGytLDVttGQRKYGGPPPDSVY |
| O60664 | Y95 | Sugiyama | PLIN3 M6PRBP1 TIP47 | VsGAQPILSKLEPQIAsAsEyAHRGLDKLEENLPILQQPTE |
| O60716 | S252 | Sugiyama | CTNND1 KIAA0384 | sRVtRIEERyRPsMEGyRAPsRQDVyGPQPQVRVGGssVDL |
| O60841 | S107 | Sugiyama | EIF5B IF2 KIAA0741 | NEEEFtsKDKKKKGQKGKKQsFDDNDsEELEDKDsKSKKTA |
| O60841 | S182 | Sugiyama | EIF5B IF2 KIAA0741 | DGsEEDEDNsKKIKERsRINssGEsGDEsDEFLQsRKGQKK |
| O60927 | T75 | Sugiyama | PPP1R11 HCGV TCTE5 | RRssKCCCIyEKPRAFGEsstEsDEEEEEGCGHtHCVRGHR |
| O75116 | Y936 | Sugiyama | ROCK2 KIAA0619 | EITLTKADSEQLARsIAEEQysDLEKEKIMKELEIKEMMAR |
| O75131 | S240 | Sugiyama | CPNE3 CPN3 KIAA0636 | DGSHDLIGTFQTTMTKLKEAsRssPVEFECINEKKRQKKKS |
| O75131 | S242 | Sugiyama | CPNE3 CPN3 KIAA0636 | SHDLIGTFQTTMTKLKEAsRssPVEFECINEKKRQKKKSYK |
| O75208 | Y93 | Sugiyama | COQ9 C16orf49 HSPC326 PSEC0129 | PEssHsPPRYTDQGGEEEEDyEsEEQLQHRILTAALEFVPA |
| O75347 | Y75 | Sugiyama | TBCA | EILQEsRMMIPDCQRRLEAAyLDLQRILENEKDLEEAEEyK |
| O75534 | Y597 | Sugiyama | CSDE1 D1S155E KIAA0885 NRU UNR | EKVNKtHsVNGItEEADPTIysGKVIRPLRSVDPTQTEYQG |
| O94826 | S91 | Sugiyama | TOMM70 KIAA0719 TOM70 TOMM70A | RGDASGLKRNSERKtPEGRAsPAPGsGHPEGPGAHLDMNsL |
| O94906 | Y105 | Sugiyama | PRPF6 C20orf14 | AGSLFSSGPYEKDDEEADAIyAALDKRMDERRKERREQREK |
| O95218 | Y167 | Sugiyama | ZRANB2 ZIS ZNF265 | EVEDKEsEGEEEDEDEDLsKyKLDEDEDEDDADLsKyNLDA |
| O95297 | Y263 | Sugiyama | MPZL1 PZR UNQ849/PRO1787 | QLDHsGGHHSDKINKSEsVVyADIRKN______________ |
| O95757 | Y629 | Sugiyama | HSPA4L APG1 HSPH3 OSP94 | MQDKLEKERNDAKNAVEEyVyDFRDRLGtVYEKFITPEDLS |
| O96019 | S233 | Sugiyama | ACTL6A BAF53 BAF53A INO80K | MNIELVPPYMIASKEAVREGsPANWKRKEKLPQVTRSWHNY |
| P00338 | Y10 | Sugiyama | LDHA PIG19 | ___________MAtLKDQLIyNLLKEEQtPQNKITVVGVGA |
| P00338 | Y239 | Sugiyama | LDHA PIG19 | GtDKDKEQWKEVHKQVVEsAyEVIKLKGYtSWAIGLSVADL |
| P00558 | Y161 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | KAEPAKIEAFRAsLSKLGDVyVNDAFGtAHRAHssMVGVNL |
| P04075 | S36 | Sugiyama | ALDOA ALDA | LsDIAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENR |
| P04075 | S39 | Sugiyama | ALDOA ALDA | IAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENRRFy |
| P04406 | S241 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | IPELNGKLtGMAFRVPtANVsVVDLtCRLEKPAKyDDIKKV |
| P04406 | T237 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | VGKVIPELNGKLtGMAFRVPtANVsVVDLtCRLEKPAKyDD |
| P04406 | Y314 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | tFDAGAGIALNDHFVKLIsWyDNEFGysNRVVDLMAHMAsK |
| P04632 | Y87 | Sugiyama | CAPNS1 CAPN4 CAPNS | sAISEAAAQYNPEPPPPRtHysNIEANEsEEVRQFRRLFAQ |
| P04792 | S82 | Sugiyama | HSPB1 HSP27 HSP28 | AIEsPAVAAPAYsRALsRQLssGVsEIRHtADRWRVsLDVN |
| P05362 | T454 | Sugiyama | ICAM1 | DGtFPLPIGEsVtVtRDLEGtyLCRARSTQGEVTRKVTVNV |
| P05362 | Y455 | Sugiyama | ICAM1 | GtFPLPIGEsVtVtRDLEGtyLCRARSTQGEVTRKVTVNVL |
| P05455 | Y104 | Sugiyama | SSB | EDKTKIRRsPsKPLPEVTDEyKNDVKNRsVYIKGFPtDAtL |
| P05787 | Y204 | Sugiyama | KRT8 CYK8 | NKRTEMENEFVLIKKDVDEAyMNKVELESRLEGLTDEINFL |
| P06733 | S268 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | ASEFFRsGKyDLDFKsPDDPsRyIsPDQLADLyKsFIKDyP |
| P06733 | Y189 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | MILPVGAANFREAMRIGAEVyHNLKNVIKEKyGKDAtNVGD |
| P06733 | Y270 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | EFFRsGKyDLDFKsPDDPsRyIsPDQLADLyKsFIKDyPVV |
| P06733 | Y280 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | DFKsPDDPsRyIsPDQLADLyKsFIKDyPVVsIEDPFDQDD |
| P06733 | Y44 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | LFtsKGLFRAAVPsGAstGIyEALELRDNDKtRYMGKGVSK |
| P06748 | S125 | Sugiyama | NPM1 NPM | GsGPVHIsGQHLVAVEEDAEsEDEEEEDVKLLsIsGKRsAP |
| P07195 | S303 | Sugiyama | LDHB | GIENEVFLSLPCILNARGLtsVINQKLKDDEVAQLKKsADt |
| P07205 | Y161 | Sugiyama | PGK2 PGKB | KAEPDKIEAFRAsLSKLGDVyVNDAFGtAHRAHSSMVGVNL |
| P07237 | Y94 | Sugiyama | P4HB ERBA2L PDI PDIA1 PO4DB | GSEIRLAKVDAtEEsDLAQQyGVRGyPtIKFFRNGDTASPK |
| P07237 | Y99 | Sugiyama | P4HB ERBA2L PDI PDIA1 PO4DB | LAKVDAtEEsDLAQQyGVRGyPtIKFFRNGDTASPKEytAG |
| P07355 | Y188 | Sugiyama | ANXA2 ANX2 ANX2L4 CAL1H LPC2D | RKLMVALAKGRRAEDGsVIDyELIDQDARDLyDAGVKRKGT |
| P07355 | Y199 | Sugiyama | ANXA2 ANX2 ANX2L4 CAL1H LPC2D | RAEDGsVIDyELIDQDARDLyDAGVKRKGTDVPKWIsIMTE |
| P07437 | T107 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | PDNFVFGQsGAGNNWAKGHytEGAELVDsVLDVVRKEAESC |
| P07437 | Y50 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | IDPTGtyHGDsDLQLDRIsVyyNEAtGGKyVPRAILVDLEP |
| P07686 | Y547 | Sugiyama | HEXB HCC7 | DRLTRHRCRMVERGIAAQPLyAGyCNHENM___________ |
| P07814 | Y827 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | EIGQNIssNssAsILESKsLyDEVAAQGEVVRKLKAEKSPK |
| P07900 | S53 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | IINtFySNKEIFLRELIsNssDALDKIRyEsLtDPsKLDsG |
| P07900 | Y160 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | SAYLVAEKVTVITKHNDDEQyAWEssAGGsFtVRTDTGEPM |
| P07900 | Y284 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | DEEEEKKDGDKKKKKKIKEKyIDQEELNKtKPIWtRNPDDI |
| P07900 | Y309 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | ELNKtKPIWtRNPDDItNEEyGEFyKsLtNDWEDHLAVKHF |
| P07900 | Y313 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | tKPIWtRNPDDItNEEyGEFyKsLtNDWEDHLAVKHFSVEG |
| P07900 | Y492 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | DEMVsLKDYCTRMKENQKHIyyItGETKDQVANsAFVERLR |
| P07900 | Y493 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | EMVsLKDYCTRMKENQKHIyyItGETKDQVANsAFVERLRK |
| P07948 | Y508 | GPS6|SIGNOR|iPTMNet|EPSD|PSP | LYN JTK8 | PTFDYLQsVLDDFytAtEGQyQQQP________________ |
| P08195 | S607 | Sugiyama | SLC3A2 MDU1 | ASLPAKADLLLstQPGREEGsPLELERLKLEPHEGLLLRFP |
| P08238 | S462 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | HEDstNRRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQKs |
| P08238 | T467 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | NRRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQKsIyyIt |
| P08238 | Y155 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | SAYLVAEKVVVITKHNDDEQyAWEssAGGsFtVRADHGEPI |
| P08238 | Y276 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | DEEDDsGKDKKKKTKKIKEKyIDQEELNKtKPIWtRNPDDI |
| P08238 | Y301 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | ELNKtKPIWtRNPDDItQEEyGEFyKsLtNDWEDHLAVKHF |
| P08238 | Y305 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | tKPIWtRNPDDItQEEyGEFyKsLtNDWEDHLAVKHFSVEG |
| P08238 | Y472 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | sELLRyHtsQsGDEMtsLsEyVsRMKEtQKsIyyItGEsKE |
| P08238 | Y484 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | DEMtsLsEyVsRMKEtQKsIyyItGEsKEQVANsAFVERVR |
| P08238 | Y485 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | EMtsLsEyVsRMKEtQKsIyyItGEsKEQVANsAFVERVRK |
| P08581 | Y1365 | Sugiyama | MET | IGEHyVHVNAtyVNVKCVAPyPSLLSSEDNADDEVDTRPAS |
| P09104 | Y44 | Sugiyama | ENO2 | LyTAKGLFRAAVPsGAstGIyEALELRDGDKQRYLGKGVLK |
| P09429 | S15 | Sugiyama | HMGB1 HMG1 | ______MGKGDPKKPRGKMssyAFFVQtCREEHKKKHPDAs |
| P09651 | S95 | Sugiyama | HNRNPA1 HNRPA1 | RPHKVDGRVVEPKRAVsREDsQRPGAHLtVKKIFVGGIKED |
| P09651 | Y341 | Sugiyama | HNRNPA1 HNRPA1 | QSSNFGPMKGGNFGGRssGPyGGGGQyFAKPRNQGGyGGss |
| P09651 | Y347 | Sugiyama | HNRNPA1 HNRPA1 | PMKGGNFGGRssGPyGGGGQyFAKPRNQGGyGGssssssyG |
| P0C7P4 | Y100 | Sugiyama | UQCRFS1P1 UQCRFSL1 | NVPASVCYSHTDIKVPDFSEyRRLEVLDSTKSSRESTEARK |
| P0CG38 | Y1062 | Sugiyama | POTEI | GGSILASLSTFQQMWISKQEyDEsGPsIVHRKCF_______ |
| P0CG39 | Y1025 | Sugiyama | POTEJ | GGSILASLSTFQQMWISKQEyDEsGPsIVHRKCF_______ |
| P10809 | Y243 | Sugiyama | HSPD1 HSP60 | yIsPyFINtsKGQKCEFQDAyVLLsEKKIssIQsIVPALEI |
| P11142 | Y41 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | FQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAM |
| P11142 | Y545 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | YKAEDEKQRDKVssKNsLEsyAFNMKATVEDEKLQGKINDE |
| P11413 | Y112 | Sugiyama | G6PD | PEEKLKLEDFFARNsyVAGQyDDAAsyQRLNsHMNALHLGs |
| P11940 | Y194 | Sugiyama | PABPC1 PAB1 PABP PABP1 PABPC2 | KSRKEREAELGARAKEFtNVyIKNFGEDMDDERLKDLFGKF |
| P12277 | Y125 | Sugiyama | CKB CKBB | EHKTDLNPDNLQGGDDLDPNyVLssRVRTGRSIRGFCLPPH |
| P12277 | Y39 | Sugiyama | CKB CKBB | EFPDLSAHNNHMAKVLtPELyAELRAKSTPSGFTLDDVIQT |
| P12814 | Y215 | Sugiyama | ACTN1 | KLRKDDPLTNLNTAFDVAEKyLDIPKMLDAEDIVGtARPDE |
| P12814 | Y842 | Sugiyama | ACTN1 | DTDTADQVMASFKILAGDKNyITMDELRRELPPDQAEyCIA |
| P13489 | S178 | Sugiyama | RNH1 PRI RNH | SCEPLASVLRAKPDFKELtVsNNDINEAGVRVLCQGLKDSP |
| P13639 | S584 | Sugiyama | EEF2 EF2 | DHACIPIKKSDPVVsyREtVsEEsNVLCLsKsPNKHNRLyM |
| P13639 | Y443 | Sugiyama | EEF2 EF2 | TGLKVRIMGPNytPGKKEDLyLKPIQRTILMMGRYVEPIED |
| P13639 | Y671 | Sugiyama | EEF2 EF2 | CFGPDGTGPNILTDITKGVQyLNEIKDSVVAGFQWATKEGA |
| P13667 | Y448 | Sugiyama | PDIA4 ERP70 ERP72 | RAATQFWRSKVLEVAKDFPEytFAIADEEDyAGEVKDLGLs |
| P13667 | Y458 | Sugiyama | PDIA4 ERP70 ERP72 | VLEVAKDFPEytFAIADEEDyAGEVKDLGLsEsGEDVNAAI |
| P13667 | Y565 | Sugiyama | PDIA4 ERP70 ERP72 | DVLIEFYAPWCGHCKQLEPVyNsLAKKYKGQKGLVIAKMDA |
| P13674 | Y282 | Sugiyama | P4HA1 P4HA | ASDDQSDQKTTPKKKGVAVDyLPERQKyEMLCRGEGIKMTP |
| P13861 | S99 | Sugiyama | PRKAR2A PKR2 PRKAR2 | EsEEDEDLEVPVPsRFNRRVsVCAEtyNPDEEEEDTDPRVI |
| P13929 | Y44 | Sugiyama | ENO3 | LHtAKGRFRAAVPsGAstGIyEALELRDGDKGRYLGKGVLK |
| P14314 | Y106 | Sugiyama | PRKCSH G19P1 | yIPSNRVNDGVCDCCDGtDEyNsGVICENtCKEKGRKEREs |
| P14625 | T171 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | GVGMtREELVKNLGTIAKsGtsEFLNKMTEAQEDGQSTSEL |
| P14625 | Y539 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | tDItsLDQyVERMKEKQDKIyFMAGsSRKEAEssPFVERLL |
| P15259 | Y92 | Sugiyama | PGAM2 PGAMM | DGTDQMWLPVVRTWRLNERHyGGLtGLNKAETAAKHGEEQV |
| P15311 | S539 | Sugiyama | EZR VIL2 | TEAEKNERVQRQLLtLssELsQARDENKRTHNDIIHNENMR |
| P15311 | Y424 | Sugiyama | EZR VIL2 | ERQAVDQIKsQEQLAAELAEytAKIALLEEARRRKEDEVEE |
| P17066 | Y43 | Sugiyama | HSPA6 HSP70B' | FQQGRVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAAL |
| P17844 | Y59 | Sugiyama | DDX5 G17P1 HELR HLR1 | EKLVKKKWNLDELPKFEKNFyQEHPDLARRtAQEVETYRRS |
| P17980 | Y381 | Sugiyama | PSMC3 TBP1 | ARARIMQIHSRKMNVsPDVNyEELARCTDDFNGAQCKAVCV |
| P18124 | Y155 | Sugiyama | RPL7 | IVEPYIAWGYPNLKsVNELIyKRGYGKINKKRIALtDNALI |
| P18206 | Y822 | Sugiyama | VCL | KAVAGNIsDPGLQKsFLDsGyRILGAVAKVREAFQPQEPDF |
| P18615 | S115 | Sugiyama | NELFE RD RDBP | KLKDPEKGPVPTFQPFQRsIsADDDLQEsSRRPQRKsLyEs |
| P18615 | Y133 | Sugiyama | NELFE RD RDBP | sIsADDDLQEsSRRPQRKsLyEsFVsssDRLRELGPDGEEA |
| P18621 | S5 | Sugiyama | RPL17 | ________________MVRysLDPENPtKsCKSRGSNLRVH |
| P18669 | S134 | Sugiyama | PGAM1 PGAMA CDABP0006 | IWRRsyDVPPPPMEPDHPFysNIsKDRRyADLtEDQLPsCE |
| P18669 | S14 | Sugiyama | PGAM1 PGAMA CDABP0006 | _______MAAYKLVLIRHGEsAWNLENRFsGWyDADLsPAG |
| P18669 | Y142 | Sugiyama | PGAM1 PGAMA CDABP0006 | PPPPMEPDHPFysNIsKDRRyADLtEDQLPsCEsLKDtIAR |
| P18669 | Y92 | Sugiyama | PGAM1 PGAMA CDABP0006 | DAIDQMWLPVVRTWRLNERHyGGLtGLNKAETAAKHGEAQV |
| P18754 | Y89 | Sugiyama | RCC1 CHC1 | VVQAEAGGMHTVCLSKsGQVysFGCNDEGALGRDtsVEGSE |
| P18858 | T183 | Sugiyama | LIG1 | sLTEAEVAtEKEGEDGDQPttPPKPLKTSKAEtPtEsVsEP |
| P19105 | Y155 | Sugiyama | MYL12A MLCB MRLC3 RLC | DEEVDELyREAPIDKKGNFNyIEFtRILKHGAKDKDD____ |
| P20618 | Y150 | Sugiyama | PSMB1 PSC5 | FPYYVYNIIGGLDEEGKGAVysFDPVGsyQRDsFKAGGSAS |
| P22234 | Y22 | Sugiyama | PAICS ADE2 AIRC PAIS | AtAEVLNIGKKLYEGKtKEVyELLDsPGKVLLQsKDQItAG |
| P22314 | S56 | Sugiyama | UBA1 A1S9T UBE1 | VPTNGMAKNGsEADIDEGLysRQLyVLGHEAMKRLQTSSVL |
| P22314 | Y55 | Sugiyama | UBA1 A1S9T UBE1 | SVPTNGMAKNGsEADIDEGLysRQLyVLGHEAMKRLQTSSV |
| P22392 | Y151 | Sugiyama | NME2 NM23B | SLWFKPEELVDyKSCAHDWVyE___________________ |
| P22626 | Y336 | Sugiyama | HNRNPA2B1 HNRPA2B1 | MKsGNFGGsRNMGGPyGGGNyGPGGsGGsGGyGGRsRy___ |
| P23246 | Y488 | Sugiyama | SFPQ PSF | PMYQKEREtPPRFAQHGtFEyEysQRWKsLDEMEKQQREQV |
| P23246 | Y490 | Sugiyama | SFPQ PSF | YQKEREtPPRFAQHGtFEyEysQRWKsLDEMEKQQREQVEK |
| P23434 | Y139 | Sugiyama | GCSH | EVTEINEALAENPGLVNKSCyEDGWLIKMtLsNPsELDELM |
| P23526 | Y193 | Sugiyama | AHCY SAHH | LKVPAINVNDsVtKsKFDNLyGCRESLIDGIKRATDVMIAG |
| P23528 | T70 | Sugiyama | CFL1 CFL | EEGKEILVGDVGQtVDDPyAtFVKMLPDKDCRyALyDAtyE |
| P23528 | Y140 | Sugiyama | CFL1 CFL | SKDAIKKKLtGIKHELQANCyEEVKDRCTLAEKLGGsAVIs |
| P23588 | S207 | Sugiyama | EIF4B | DRNRDsDKtDTDWRARPAtDsFDDyPPRRGDDsFGDKYRDR |
| P24752 | Y214 | Sugiyama | ACAT1 ACAT MAT | GsCAENTAKKLNIARNEQDAyAINsytRSKAAWEAGKFGNE |
| P24941 | T160 | Sugiyama | CDK2 CDKN2 | AIKLADFGLARAFGVPVRtytHEVVtLWyRAPEILLGCKYY |
| P25205 | Y32 | Sugiyama | MCM3 | LREAQRDyLDFLDDEEDQGIyQsKVRELIsDNQyRLIVNVN |
| P25205 | Y456 | Sugiyama | MCM3 | AGIHARLNARCsVLAAANPVyGRyDQyKTPMENIGLQDSLL |
| P26373 | S77 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | PIVRCPTVRYHTKVRAGRGFsLEELRVAGIHKKVARTIGIs |
| P26583 | S15 | Sugiyama | HMGB2 HMG2 | ______MGKGDPNKPRGKMssyAFFVQtCREEHKKKHPDss |
| P27348 | Y149 | Sugiyama | YWHAQ | LAEVACGDDRKQtIDNsQGAyQEAFDIsKKEMQPTHPIRLG |
| P27540 | Y561 | Sugiyama | ARNT BHLHE2 | PLEKSDGLFAQDRDPRFsEIyHNINADQSKGISSSTVPATQ |
| P27695 | Y128 | Sugiyama | APEX1 APE APE1 APEX APX HAP1 REF1 | LQELPGLSHQYWSAPsDKEGysGVGLLsRQCPLKVsyGIGD |
| P27695 | Y45 | Sugiyama | APEX1 APE APE1 APEX APX HAP1 REF1 | KSKTAAKKNDKEAAGEGPALyEDPPDQKtsPsGKPAtLKIC |
| P27816 | Y47 | Sugiyama | MAP4 | AtLEAEAFDDVVGETVGKTDyIPLLDVDEKtGNsESKKKPC |
| P27824 | S362 | Sugiyama | CANX | WDEDMDGEWEAPQIANPRCEsAPGCGVWQRPVIDNPNyKGK |
| P29401 | Y481 | Sugiyama | TKT | AANTKGICFIRTsRPENAIIyNNNEDFQVGQAKVVLKSKDD |
| P29692 | Y26 | Sugiyama | EEF1D EF1D | LAHEKIWFDKFKYDDAERRFyEQMNGPVAGAsRQENGAsVI |
| P30043 | Y205 | Sugiyama | BLVRB FLR SCAN | MLRCLttDEyDGHstyPsHQyQ___________________ |
| P30085 | Y49 | Sugiyama | CMPK1 CMK CMPK UCK UMK UMPK | ytHLSAGELLRDERKNPDsQyGELIEKYIKEGKIVPVEITI |
| P30086 | S52 | Sugiyama | PEBP1 PBP PEBP | AAVDELGKVLtPtQVKNRPtsIsWDGLDsGKLytLVLtDPD |
| P30086 | T65 | Sugiyama | PEBP1 PBP PEBP | QVKNRPtsIsWDGLDsGKLytLVLtDPDAPsRKDPKYREWH |
| P30086 | Y64 | Sugiyama | PEBP1 PBP PEBP | tQVKNRPtsIsWDGLDsGKLytLVLtDPDAPsRKDPKYREW |
| P30101 | Y115 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | yGVsGyPtLKIFRDGEEAGAyDGPRtADGIVsHLKKQAGPA |
| P30101 | Y445 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | KDPNIVIAKMDAtANDVPsPyEVRGFPtIyFsPANKKLNPK |
| P30101 | Y479 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | NKKLNPKKyEGGRELsDFIsyLQREAtNPPVIQEEKPKKKK |
| P30101 | Y67 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | LMLVEFFAPWCGHCKRLAPEyEAAAtRLKGIVPLAKVDCTA |
| P31153 | Y242 | Sugiyama | MAT2A AMS2 MATA2 | LKEKVIKAVVPAKyLDEDtIyHLQPsGRFVIGGPQGDAGLt |
| P31943 | Y266 | Sugiyama | HNRNPH1 HNRPH HNRPH1 | yNGYNDGYGFGSDRFGRDLNyCFsGMsDHRyGDGGstFQst |
| P31946 | Y151 | Sugiyama | YWHAB | LsEVAsGDNKQTtVsNsQQAyQEAFEIsKKEMQPTHPIRLG |
| P31946 | Y21 | Sugiyama | YWHAB | MTMDKsELVQKAKLAEQAERyDDMAAAMKAVtEQGHELsNE |
| P31948 | Y354 | Sugiyama | STIP1 | DVLKKCQQAEKILKEQERLAyINPDLALEEKNKGNECFQKG |
| P31948 | Y41 | Sugiyama | STIP1 | DDALQCysEAIKLDPHNHVLysNRsAAyAKKGDYQKAyEDG |
| P32969 | Y180 | Sugiyama | RPL9 OK/SW-cl.103; RPL9P7; RPL9P8; RPL9P9 | LIQQATTVKNKDIRKFLDGIyVsEKGtVQQADE________ |
| P33176 | Y516 | Sugiyama | KIF5B KNS KNS1 | EELAVNyDQKSQEVEDKTKEyELLSDELNQKsATLAsIDAE |
| P33316 | Y167 | Sugiyama | DUT | PPMEKAVVKTDIQIALPsGCyGRVAPRSGLAAKHFIDVGAG |
| P34931 | Y43 | Sugiyama | HSPA1L | FQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAM |
| P34932 | Y30 | Sugiyama | HSPA4 APG2 HSPH2 | FQSCYVAVARAGGIETIANEysDRCtPACIsFGPKNRSIGA |
| P34932 | Y336 | Sugiyama | HSPA4 APG2 HSPH2 | RVEPPLRSVLEQTKLKKEDIyAVEIVGGATRIPAVKEKISK |
| P34932 | Y626 | Sugiyama | HSPA4 APG2 HSPH2 | MQDKLEKERNDAKNAVEEyVyEMRDKLSGEYEKFVSEDDRN |
| P35221 | S641 | Sugiyama | CTNNA1 | GIRDIRKAVLMIRtPEELDDsDFEtEDFDVRsRtsVQtEDD |
| P35269 | T389 | Sugiyama | GTF2F1 RAP74 | PPKRERKPsGGSSRGNsRPGtPsAEGGstsstLRAAASKLE |
| P37802 | T190 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | GKNVIGLQMGtNRGAsQAGMtGyGMPRQIL___________ |
| P37802 | Y192 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | NVIGLQMGtNRGAsQAGMtGyGMPRQIL_____________ |
| P38646 | S89 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | VMEGKQAKVLENAEGARttPsVVAFtADGERLVGMPAKRQA |
| P38646 | Y118 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | ERLVGMPAKRQAVtNPNNtFyAtKRLIGRRYDDPEVQKDIK |
| P39019 | Y48 | Sugiyama | RPS19 | LKVPEWVDtVKLAKHKELAPyDENWFytRAAstARHLYLRG |
| P39019 | Y54 | Sugiyama | RPS19 | VDtVKLAKHKELAPyDENWFytRAAstARHLYLRGGAGVGs |
| P39023 | S13 | Sugiyama | RPL3 OK/SW-cl.32 | ________MSHRKFSAPRHGsLGFLPRKRSSRHRGKVKSFP |
| P39023 | S265 | Sugiyama | RPL3 OK/SW-cl.32 | HRGLRKVACIGAWHPARVAFsVARAGQKGYHHRTEINKKIY |
| P40429 | Y149 | Sugiyama | RPL13A | LKPTRKFAYLGRLAHEVGWKyQAVtAtLEEKRKEKAKIHYR |
| P40925 | Y210 | Sugiyama | MDH1 MDHA | tQYPDVNHAKVKLQGKEVGVyEALKDDsWLKGEFVttVQQR |
| P42166 | S159 | Sugiyama | TMPO LAP2 | RKLYEKKLLKLREQGtEsRsstPLPtIsssAENtRQNGsND |
| P42166 | T160 | Sugiyama | TMPO LAP2 | KLYEKKLLKLREQGtEsRsstPLPtIsssAENtRQNGsNDs |
| P42167 | S159 | Sugiyama | TMPO LAP2 | RKLYEKKLLKLREQGTESRsstPLPTISsSAENTRQNGSND |
| P42167 | T160 | Sugiyama | TMPO LAP2 | KLYEKKLLKLREQGTESRsstPLPTISsSAENTRQNGSNDS |
| P42224 | Y170 | Sugiyama | STAT1 | KDKVMCIEHEIKsLEDLQDEyDFKCKTLQNREHETNGVAKS |
| P42679 | S18 | Sugiyama | MATK CTK HYL | ___MAGRGSLVSWRAFHGCDsAEELPRVsPRFLRAWHPPPV |
| P42679 | S501 | Sugiyama | MATK CTK HYL | ELRsAGAPASVsGQDADGstsPRsQEP______________ |
| P42679 | S504 | Sugiyama | MATK CTK HYL | sAGAPASVsGQDADGstsPRsQEP_________________ |
| P43243 | S188 | Sugiyama | MATR3 KIAA0723 | EPPyRVPRDDWEEKRHFRRDsFDDRGPsLNPVLDyDHGsRs |
| P43243 | Y202 | Sugiyama | MATR3 KIAA0723 | RHFRRDsFDDRGPsLNPVLDyDHGsRsQEsGyyDRMDyEDD |
| P43487 | S60 | Sugiyama | RANBP1 | TLEEDEEELFKMRAKLFRFAsENDLPEWKERGTGDVKLLKH |
| P43490 | Y34 | Sugiyama | NAMPT PBEF PBEF1 | ATDSYKVTHYKQYPPNTSKVysyFECREKKTENSKLRKVKY |
| P45974 | Y849 | Sugiyama | USP5 ISOT | WVIYNDQKVCASEKPPKDLGyIyFyQRVAS___________ |
| P45974 | Y851 | Sugiyama | USP5 ISOT | IYNDQKVCASEKPPKDLGyIyFyQRVAS_____________ |
| P45974 | Y853 | Sugiyama | USP5 ISOT | NDQKVCASEKPPKDLGyIyFyQRVAS_______________ |
| P46063 | Y61 | Sugiyama | RECQL RECQ1 RECQL1 | VLTKKIKQCLEDsDAGAsNEyDssPAAWNKEDFPWSGKVKD |
| P46777 | Y226 | Sugiyama | RPL5 MSTP030 | DyMRyLMEEDEDAyKKQFsQyIKNsVtPDMMEEMyKKAHAA |
| P46777 | Y253 | Sugiyama | RPL5 MSTP030 | PDMMEEMyKKAHAAIRENPVyEKKPKKEVKKKRWNRPKMsL |
| P46778 | T29 | Sugiyama | RPL21 | RGTRYMFSRPFRKHGVVPLAtyMRIYKKGDIVDIKGMGTVQ |
| P46937 | Y407 | Sugiyama | YAP1 YAP65 | NsGtyHsRDEstDsGLsMssysVPRtPDDFLNsVDEMDTGD |
| P47756 | Y59 | Sugiyama | CAPZB | LLSSVDQPLKIARDKVVGKDyLLCDyNRDGDSyRsPWSNKy |
| P47813 | Y35 | Sugiyama | EIF1AX EIF1A EIF4C | GKNENESEKRELVFKEDGQEyAQVIKMLGNGRLEAMCFDGV |
| P47914 | Y98 | Sugiyama | RPL29 | PKEVKPKIPKGVSRKLDRLAyIAHPKLGKRARARIAKGLRL |
| P47985 | Y91 | Sugiyama | UQCRFS1 | NVPASVCYSHTDIKVPDFSEyRRLEVLDstKSSRESSEARK |
| P48741 | Y43 | Sugiyama | HSPA7 HSP70B | FQQGRVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAAL |
| P49023 | Y118 | Sugiyama | PXN | sNPQDsVGsPCsRVGEEEHVysFPNKQKsAEPsPtVMstsL |
| P49023 | Y88 | Sugiyama | PXN | QWQPSSSRFIHQQPQsssPVyGssAKtssVsNPQDsVGsPC |
| P49207 | Y32 | Sugiyama | RPL34 | sYNtASNKTRLSRTPGNRIVyLytKKVGKAPKSACGVCPGR |
| P49321 | Y540 | Sugiyama | NASP | DMLDLAKIIFKRQETKEAQLyAAQAHLKLGEVSVESENYVQ |
| P49327 | Y45 | Sugiyama | FASN FAS | NLIGGVDMVTDDDRRWKAGLyGLPRRsGKLKDLSRFDAsFF |
| P49840 | Y279 | Sugiyama | GSK3A | LKLCDFGSAKQLVRGEPNVsyICsRYYRAPELIFGATDYTS |
| P49841 | Y216 | Sugiyama | GSK3B | LKLCDFGSAKQLVRGEPNVsyICsRYYRAPELIFGATDYTS |
| P50613 | S164 | Sugiyama | CDK7 CAK CAK1 CDKN7 MO15 STK1 | LLDENGVLKLADFGLAKsFGsPNRAytHQVVtRWYRAPELL |
| P50990 | Y30 | Sugiyama | CCT8 C21orf112 CCTQ KIAA0002 | GFAQMLKEGAKHFsGLEEAVyRNIQACKELAQTTRTAYGPN |
| P50991 | Y269 | Sugiyama | CCT4 CCTD SRB | IQFCLSAPKTDMDNQIVVSDyAQMDRVLREERAYILNLVKQ |
| P51965 | Y77 | Sugiyama | UBE2E1 UBCH6 | ADITLDPPPNCSAGPKGDNIyEWRSTILGPPGSVYEGGVFF |
| P52565 | Y156 | Sugiyama | ARHGDIA GDIA1 | GVKIDKtDyMVGsYGPRAEEyEFLtPVEEAPKGMLARGsYs |
| P54652 | Y42 | Sugiyama | HSPA2 | FQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAM |
| P55060 | Y369 | Sugiyama | CSE1L CAS XPO2 | VPNMEFRAADEEAFEDNsEEyIRRDLEGsDIDTRRRAACDL |
| P55795 | Y266 | Sugiyama | HNRNPH2 FTP3 HNRPH2 | YGGYNDGYGFGSDRFGRDLNyCFsGMsDHRyGDGGssFQst |
| P60174 | Y209 | Sugiyama | TPI1 TPI | LRGWLKsNVsDAVAQstRIIyGGsVtGAtCKELASQPDVDG |
| P60660 | Y89 | Sugiyama | MYL6 | HFLPMLQTVAKNKDQGtyEDyVEGLRVFDKEGNGtVMGAEI |
| P60709 | T297 | Sugiyama | ACTB | TTFNSIMKCDVDIRKDLyANtVLsGGttMyPGIADRMQKEI |
| P60709 | Y198 | Sugiyama | ACTB | LDLAGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCy |
| P60709 | Y240 | Sugiyama | ACTB | ALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPEA |
| P60709 | Y306 | Sugiyama | ACTB | DVDIRKDLyANtVLsGGttMyPGIADRMQKEItALAPstMK |
| P60709 | Y362 | Sugiyama | ACTB | GGsILAsLstFQQMWISKQEyDEsGPsIVHRKCF_______ |
| P61247 | Y256 | Sugiyama | RPS3A FTE1 MFTL | sssGKAtGDEtGAKVERADGyEPPVQEsV____________ |
| P61254 | T8 | Sugiyama | RPL26 | _____________MKFNPFVtsDRsKNRKRHFNAPsHIRRK |
| P61313 | Y62 | Sugiyama | RPL15 EC45 TCBAP0781 | PTRPDKARRLGYKAKQGyVIyRIRVRRGGRKRPVPKGAtyG |
| P61604 | Y88 | Sugiyama | HSPE1 | GDKVLLPEyGGtKVVLDDKDyFLFRDGDILGKyVD______ |
| P61978 | S75 | Sugiyama | HNRNPK HNRPK | GAVIGKGGKNIKALRtDyNAsVsVPDssGPERILsISADIE |
| P61978 | Y323 | Sugiyama | HNRNPK HNRPK | RARNLPLPPPPPPRGGDLMAyDRRGRPGDRYDGMVGFSADE |
| P61981 | Y20 | Sugiyama | YWHAG | _MVDREQLVQKARLAEQAERyDDMAAAMKNVtELNEPLsNE |
| P62081 | Y177 | Sugiyama | RPS7 | HLDKAQQNNVEHKVEtFsGVyKKLTGKDVNFEFPEFQL___ |
| P62191 | Y184 | Sugiyama | PSMC1 | MDDTDPLVTVMKVEKAPQETyADIGGLDNQIQEIKESVELP |
| P62258 | Y152 | Sugiyama | YWHAE | LAEFAtGNDRKEAAENsLVAyKAAsDIAMtELPPTHPIRLG |
| P62263 | T133 | Sugiyama | RPS14 PRO2640 | QsALRALARSGMKIGRIEDVtPIPsDstRRKGGRRGRRL__ |
| P62269 | S96 | Sugiyama | RPS18 D6S218E | QYKIPDWFLNRQKDVKDGKysQVLANGLDNKLREDLERLKK |
| P62269 | Y95 | Sugiyama | RPS18 D6S218E | RQYKIPDWFLNRQKDVKDGKysQVLANGLDNKLREDLERLK |
| P62273 | Y7 | Sugiyama | RPS29 | ______________MGHQQLyWsHPRKFGQGSRSCRVCSNR |
| P62277 | S12 | Sugiyama | RPS13 | _________MGRMHAPGKGLsQsALPyRRsVPtWLKLTsDD |
| P62277 | S14 | Sugiyama | RPS13 | _______MGRMHAPGKGLsQsALPyRRsVPtWLKLTsDDVK |
| P62280 | Y55 | Sugiyama | RPS11 | RYYKNIGLGFKtPKEAIEGtyIDKKCPFTGNVsIRGRILsG |
| P62736 | Y242 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P62750 | Y144 | Sugiyama | RPL23A | VNtLIRPDGEKKAYVRLAPDyDALDVANKIGII________ |
| P62750 | Y74 | Sugiyama | RPL23A | LRRQPKYPRKSAPRRNKLDHyAIIKFPLTTEsAMKKIEDNN |
| P62753 | Y156 | Sugiyama | RPS6 OK/SW-cl.2 | KRASRIRKLFNLsKEDDVRQyVVRKPLNKEGKKPRTKAPKI |
| P62826 | Y146 | Sugiyama | RAN ARA24 OK/SW-cl.81 | IKDRKVKAKsIVFHRKKNLQyyDIsAKSNyNFEKPFLWLAR |
| P62906 | T9 | Sugiyama | RPL10A NEDD6 | ____________MSSKVsRDtLyEAVREVLHGNQRKRRKFL |
| P62906 | Y11 | Sugiyama | RPL10A NEDD6 | __________MSSKVsRDtLyEAVREVLHGNQRKRRKFLET |
| P62913 | Y170 | Sugiyama | RPL11 | CIGAKHRISKEEAMRWFQQKyDGIILPGK____________ |
| P62917 | S130 | Sugiyama | RPL8 | GTIVCCLEEKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKL |
| P62917 | Y133 | Sugiyama | RPL8 | VCCLEEKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKLPSG |
| P62979 | Y148 | Sugiyama | RPS27A UBA80 UBCEP1 | AGVFMAsHFDRHyCGKCCLtyCFNKPEDK____________ |
| P63173 | T14 | Sugiyama | RPL38 | _______MPRKIEEIKDFLLtARRKDAKSVKIKKNKDNVKF |
| P63220 | Y53 | Sugiyama | RPS21 | QMNVAEVDKVTGRFNGQFKtyAICGAIRRMGEsDDsILRLA |
| P63261 | T297 | Sugiyama | ACTG1 ACTG | TTFNSIMKCDVDIRKDLyANtVLsGGttMyPGIADRMQKEI |
| P63261 | Y198 | Sugiyama | ACTG1 ACTG | LDLAGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCy |
| P63261 | Y240 | Sugiyama | ACTG1 ACTG | ALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPEA |
| P63261 | Y306 | Sugiyama | ACTG1 ACTG | DVDIRKDLyANtVLsGGttMyPGIADRMQKEItALAPstMK |
| P63261 | Y362 | Sugiyama | ACTG1 ACTG | GGsILAsLstFQQMWISKQEyDEsGPsIVHRKCF_______ |
| P63267 | Y241 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P67809 | S209 | Sugiyama | YBX1 NSEP1 YB1 | RRRRFPPyyMRRPYGRRPQysNPPVQGEVMEGADNQGAGEQ |
| P67809 | Y208 | Sugiyama | YBX1 NSEP1 YB1 | yRRRRFPPyyMRRPYGRRPQysNPPVQGEVMEGADNQGAGE |
| P67809 | Y72 | Sugiyama | YBX1 NSEP1 YB1 | KKVIATKVLGTVKWFNVRNGyGFINRNDtKEDVFVHQtAIK |
| P67809 | Y99 | Sugiyama | YBX1 NSEP1 YB1 | DtKEDVFVHQtAIKKNNPRKyLRsVGDGEtVEFDVVEGEKG |
| P68032 | Y242 | Sugiyama | ACTC1 ACTC | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P68104 | Y254 | Sugiyama | EEF1A1 EEF1A EF1A LENG7 | CILPPtRPTDKPLRLPLQDVyKIGGIGtVPVGRVEtGVLKP |
| P68104 | Y29 | Sugiyama | EEF1A1 EEF1A EF1A LENG7 | NIVVIGHVDsGKstttGHLIyKCGGIDKRTIEKFEKEAAEM |
| P68133 | Y242 | Sugiyama | ACTA1 ACTA | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P68363 | Y312 | Sugiyama | TUBA1B | tNACFEPANQMVKCDPRHGKyMACCLLyRGDVVPKDVNAAI |
| P68363 | Y432 | Sugiyama | TUBA1B | GMEEGEFSEAREDMAALEKDyEEVGVDsVEGEGEEEGEEy_ |
| P68363 | Y451 | Sugiyama | TUBA1B | DyEEVGVDsVEGEGEEEGEEy____________________ |
| P68366 | Y312 | Sugiyama | TUBA4A TUBA1 | tNACFEPANQMVKCDPRHGKyMACCLLyRGDVVPKDVNAAI |
| P78324 | Y429 | EPSD|PSP | SIRPA BIT MFR MYD1 PTPNS1 SHPS1 SIRP | RLHEPEKNAREITQDTNDItyADLNLPKGKKPAPQAAEPNN |
| P78324 | Y453 | EPSD|PSP | SIRPA BIT MFR MYD1 PTPNS1 SHPS1 SIRP | NLPKGKKPAPQAAEPNNHTEyASIQTSPQPASEDTLTyADL |
| P78345 | S253 | Sugiyama | RPP38 | DtsFEDLsKPKRKLADGRQAsVtLQPLKIKKLIPNPNKIRK |
| P85037 | S445 | Sugiyama | FOXK1 MNF | GLMsPRsGGLQtPECLsREGsPIPHDPEFGsKLASVPEYRY |
| P98082 | Y38 | Sugiyama | DAB2 DOC2 | AAPKAPsKKEKKKGPEKTDEyLLARFKGDGVKYKAKLIGID |
| Q00526 | T160 | Sugiyama | CDK3 CDKN3 | AIKLADFGLARAFGVPLRtYtHEVVTLWYRAPEILLGSKFY |
| Q00613 | S363 | Sugiyama | HSF1 HSTF1 | AsVTALtDARGHTDtEGRPPsPPPtstPEKCLsVACLDKNE |
| Q00839 | Y257 | Sugiyama | HNRNPU C1orf199 HNRPU SAFA U21.1 | QKGGDKKRGVKRPREDHGRGyFEyIEENKysRAKsPQPPVE |
| Q00839 | Y260 | Sugiyama | HNRNPU C1orf199 HNRPU SAFA U21.1 | GDKKRGVKRPREDHGRGyFEyIEENKysRAKsPQPPVEEED |
| Q01105 | Y146 | Sugiyama | SET | tEFEDIKsGyRIDFyFDENPyFENKVLSKEFHLNEsGDPss |
| Q04446 | Y657 | Sugiyama | GBE1 | RVGTALPGKFKIVLDSDAAEyGGHQRLDHSTDFFSEAFEHN |
| Q04837 | S67 | Sugiyama | SSBP1 SSBP | QVEGKNPVTIFSLATNEMWRsGDsEVyQLGDVsQKTTWHRI |
| Q04837 | Y73 | Sugiyama | SSBP1 SSBP | PVTIFSLATNEMWRsGDsEVyQLGDVsQKTTWHRISVFRPG |
| Q05639 | Y254 | Sugiyama | EEF1A2 EEF1AL STN | TILPPTRPTDKPLRLPLQDVyKIGGIGtVPVGRVETGILRP |
| Q05639 | Y29 | Sugiyama | EEF1A2 EEF1AL STN | NIVVIGHVDsGKstttGHLIyKCGGIDKRTIEKFEKEAAEM |
| Q06210 | S261 | Sugiyama | GFPT1 GFAT GFPT | GsQGERGKDKKGSCNLsRVDsttCLFPVEEKAVEyyFASDA |
| Q06830 | Y116 | Sugiyama | PRDX1 PAGA PAGB TDPX2 | GLGPMNIPLVSDPKRtIAQDyGVLKADEGIsFRGLFIIDDK |
| Q07666 | S20 | Sugiyama | KHDRBS1 SAM68 | _MQRRDDPAARMsRssGRsGsMDPsGAHPsVRQtPsRQPPL |
| Q07666 | Y145 | Sugiyama | KHDRBS1 SAM68 | LtAEIEKIQKGDSKKDDEENyLDLFsHKNMKLKERVLIPVK |
| Q07955 | Y189 | Sugiyama | SRSF1 ASF SF2 SF2P33 SFRS1 OK/SW-cl.3 | TYAVRKLDNTKFRsHEGEtAyIRVKVDGPRsPsyGRsRsRs |
| Q08043 | Y229 | Sugiyama | ACTN3 | KLRKDDPIGNLNTAFEVAEKyLDIPKMLDAEDIVNtPKPDE |
| Q08830 | Y80 | Sugiyama | FGL1 HFREP1 | VQFLDKGDENTVIDLGSKRQyADCSEIFNDGyKLSGFYKIK |
| Q12996 | Y708 | Sugiyama | CSTF3 | NEDsDEDEEKGAVVPPVHDIyRARQQKRIR___________ |
| Q13228 | Y28 | Sugiyama | SELENBP1 SBP | CGPGySTPLEAMKGPREEIVyLPCIyRNtGtEAPDyLATVD |
| Q13247 | S303 | Sugiyama | SRSF6 SFRS6 SRP55 | ENGKGDIKsKSRsRsQsRsNsPLPVPPsKARsVsPPPKRAT |
| Q13263 | Y133 | Sugiyama | TRIM28 KAP1 RNF96 TIF1B | TVVDCPVCKQQCFSKDIVENyFMRDsGsKAATDAQDANQCC |
| Q13263 | Y242 | Sugiyama | TRIM28 KAP1 RNF96 TIF1B | ESCDTLTCRDCQLNAHKDHQyQFLEDAVRNQRKLLAsLVKR |
| Q13283 | S231 | Sugiyama | G3BP1 G3BP | QEEKPEPVLEETAPEDAQKsssPAPADIAQtVQEDLRtFsW |
| Q13283 | S232 | Sugiyama | G3BP1 G3BP | EEKPEPVLEETAPEDAQKsssPAPADIAQtVQEDLRtFsWA |
| Q13310 | Y194 | Sugiyama | PABPC4 APP1 PABP4 | KSRKEREAELGAKAKEFtNVyIKNFGEEVDDEsLKELFsQF |
| Q13404 | Y145 | Sugiyama | UBE2V1 CROC1 UBE2V UEV1 P/OKcl.19 | RRLMMSKENMKLPQPPEGQCysN__________________ |
| Q13405 | Y45 | Sugiyama | MRPL49 C11orf4 NOF1 OK/SW-cl.67 | LLSQTQGPPDYPRFVEsVDEyQFVERLLPATRIPDPPKHEH |
| Q13442 | Y17 | Sugiyama | PDAP1 HASPP28 | ____MPKGGRKGGHKGRARQytsPEEIDAQLQAEKQKAREE |
| Q13509 | T107 | Sugiyama | TUBB3 TUBB4 | PDNFIFGQSGAGNNWAKGHytEGAELVDsVLDVVRKECENC |
| Q13561 | Y6 | Sugiyama | DCTN2 DCTN50 | _______________MADPKyADLPGIARNEPDVYETSDLP |
| Q13561 | Y86 | Sugiyama | DCTN2 DCTN50 | GLDFsDRIGKTKRtGyEsGEyEMLGEGLGVKETPQQKYQRL |
| Q13601 | Y287 | Sugiyama | KRR1 HRB2 | tPFPPPQPESQIDKELAsGEyFLKANQKKRQKMEAIKAKQA |
| Q13765 | S117 | Sugiyama | NACA HSD48 | RKSKNILFVITKPDVYKSPAsDtyIVFGEAKIEDLsQQAQL |
| Q13765 | Y120 | Sugiyama | NACA HSD48 | KNILFVITKPDVYKSPAsDtyIVFGEAKIEDLsQQAQLAAA |
| Q13885 | T107 | Sugiyama | TUBB2A TUBB2 | PDNFVFGQsGAGNNWAKGHytEGAELVDsVLDVVRKESESC |
| Q14126 | Y968 | Sugiyama | DSG2 CDHF5 | PTTVILGPSQPQSLIVTERVyAPAstLVDQPyANEGtVVVT |
| Q14152 | S584 | Sugiyama | EIF3A EIF3S10 KIAA0139 | EHQRILARRQtIEERKERLEsLNIQREKEELEQREAELQKV |
| Q14155 | S518 | Sugiyama | ARHGEF7 COOL1 KIAA0142 P85SPR PAK3BP PIXB Nbla10314 | ERYLLLFPNVLLMLSASPRMsGFIyQGKLPtTGMTITKLED |
| Q14247 | S447 | Sugiyama | CTTN EMS1 | FKAELsyRGPVsGtEPEPVysMEAADyREASSQQGLAYATE |
| Q14247 | Y334 | Sugiyama | CTTN EMS1 | KDRMDKNAstFEDVtQVssAyQKTVPVEAVtsKtsNIRANF |
| Q14247 | Y421 | Sugiyama | CTTN EMS1 | tPPVsPAPQPtEERLPssPVyEDAAsFKAELsyRGPVsGtE |
| Q14247 | Y446 | Sugiyama | CTTN EMS1 | sFKAELsyRGPVsGtEPEPVysMEAADyREASSQQGLAYAT |
| Q14444 | Y99 | Sugiyama | CAPRIN1 GPIAP1 GPIP137 M11S1 RNG105 | QERMNKGERLNQDQLDAVsKyQEVtNNLEFAKELQRsFMAL |
| Q14568 | S53 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | IINTFYSNKEIFLRELIsNssDALDKIWYESLTDPSKLDSG |
| Q14568 | Y160 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | SAYLVAEKVTVITKHNDDEQyAWEssAGGsFtVRTDTGERM |
| Q14568 | Y283 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | sDEEEEKKDGDKKKKKTKEKyIDQEELNKTKPIWTRNPDDI |
| Q14693 | S434 | Sugiyama | LPIN1 KIAA0188 | FPKNGDPSGLAKHASDNGARsANQsPQSVGSSGVDSGVEST |
| Q14693 | S438 | Sugiyama | LPIN1 KIAA0188 | GDPSGLAKHASDNGARsANQsPQSVGSSGVDSGVESTSDGL |
| Q14974 | Y529 | Sugiyama | KPNB1 NTF97 | KLLETTDRPDGHQNNLRSSAyEsLMEIVKNSAKDCYPAVQK |
| Q14CX7 | Y19 | Sugiyama | NAA25 C12orf30 MDM20 NAP1 | __MATRGHVQDPNDRRLRPIyDyLDNGNNKMAIQQADKLLK |
| Q14CX7 | Y21 | Sugiyama | NAA25 C12orf30 MDM20 NAP1 | MATRGHVQDPNDRRLRPIyDyLDNGNNKMAIQQADKLLKKH |
| Q15024 | Y13 | Sugiyama | EXOSC7 KIAA0116 RRP42 | ________MASVTLSEAEKVyIVHGVQEDLRVDGRGCEDYR |
| Q15052 | S488 | Sugiyama | ARHGEF6 COOL2 KIAA0006 PIXA | ERYLMLFSNVLIMLSASPRMsGFIYQGKIPIAGTVVTRLDE |
| Q15293 | Y278 | Sugiyama | RCN1 RCN | LNKDGKLDKDEIRHWILPQDyDHAQAEARHLVyESDKNKDE |
| Q15369 | Y8 | Sugiyama | ELOC TCEB1 | _____________MDGEEKtyGGCEGPDAMyVKLISSDGHE |
| Q15427 | Y16 | Sugiyama | SF3B4 SAP49 | _____MAAGPISERNQDAtVyVGGLDEKVSEPLLWELFLQA |
| Q15459 | S451 | Sugiyama | SF3A1 SAP114 | IGLLDPRWLEQRDRSIREKQsDDEVyAPGLDIESsLKQLAE |
| Q15459 | Y456 | Sugiyama | SF3A1 SAP114 | PRWLEQRDRSIREKQsDDEVyAPGLDIESsLKQLAERRtDI |
| Q15527 | Y123 | Sugiyama | SURF2 | GRRYQRALCKYEECQKQGVEyVPACLVHRRRRREDQMDGDG |
| Q15785 | Y25 | Sugiyama | TOMM34 URCC3 | FPDsVEELRAAGNESFRNGQyAEASALyGRALRVLQAQGss |
| Q15785 | Y54 | Sugiyama | TOMM34 URCC3 | RALRVLQAQGssDPEEEsVLysNRAACHLKDGNCRDCIKDC |
| Q16513 | T958 | Sugiyama | PKN2 PRK2 PRKCL2 | RGREDVSNFDDEFtsEAPILtPPREPRILsEEEQEMFRDFD |
| Q1KMD3 | Y215 | Sugiyama | HNRNPUL2 HNRPUL2 | GERRGVKRQRDEKDEHGRAyyEFREEAYHsRsKsPLPPEEE |
| Q27J81 | T1206 | Sugiyama | INF2 C14orf151 C14orf173 | DtsLDKsFsEDAVtDssGsGtLPRARGRASKGTGKRRKKRP |
| Q32MZ4 | Y597 | Sugiyama | LRRFIP1 GCF2 TRIP | KKKKsPVPVETLKDVKKELtyQNTDLsEIKEEEQVKstDRK |
| Q32P51 | S95 | Sugiyama | HNRNPA1L2 HNRNPA1L | TPHKVDGRVVEPKRAVsREDsQRPGAHLtVKKIFVGGIKED |
| Q562R1 | Y241 | Sugiyama | ACTBL2 | ALDFEQEMVRAAAssSPERsyELPDGQVItIGNERFRCPEA |
| Q58FF8 | Y198 | Sugiyama | HSP90AB2P HSP90BB | DEEDDsGKDKKKKTKKIKEKyIDQEELNKTKPIWTRNTEDI |
| Q58FF8 | Y260 | Sugiyama | HSP90AB2P HSP90BB | VRYFSVEEYVSRMKEIQKsIyyItGEsKEQVANSAFVEQVW |
| Q58FF8 | Y261 | Sugiyama | HSP90AB2P HSP90BB | RYFSVEEYVSRMKEIQKsIyyItGEsKEQVANSAFVEQVWK |
| Q58FG0 | Y177 | Sugiyama | HSP90AA5P HSP90AE | GQLEELKDSRRVMKANQKHIyyItGETKDQVANSAFVECLQ |
| Q58FG0 | Y178 | Sugiyama | HSP90AA5P HSP90AE | QLEELKDSRRVMKANQKHIyyItGETKDQVANSAFVECLQK |
| Q5T035 | T62 | Sugiyama | FAM120A2P C9orf129 | yPysLSEPAPLTLDTSGKNLtEQNsysNIPHEGKHtPLyER |
| Q5T035 | Y67 | Sugiyama | FAM120A2P C9orf129 | SEPAPLTLDTSGKNLtEQNsysNIPHEGKHtPLyERSLPIN |
| Q5VTE0 | Y254 | Sugiyama | EEF1A1P5 EEF1AL3 | CILPPtRPTDKPLRLPLQDVyKIGGIGtVPVGRVEtGVLKP |
| Q5VTE0 | Y29 | Sugiyama | EEF1A1P5 EEF1AL3 | NIVVIGHVDsGKstttGHLIyKCGGIDKRTIEKFEKEAAEM |
| Q5VV41 | Y216 | Sugiyama | ARHGEF16 EPHEXIN4 NBR | KKTLGRKRGHKGsFKDDPQLyQEIQERGLNtsQEsDDDILD |
| Q63ZY3 | S356 | Sugiyama | KANK2 ANKRD25 KIAA1518 MXRA3 SIP | PREVEVVASTAAGAPAQRAQsLEPYGtGLRALAMPGRPEsP |
| Q6PCE3 | S175 | Sugiyama | PGM2L1 BM32A | PFVPYAVQKLKAVAGVMItAsHNRKEDNGYKVYWETGAQIT |
| Q6PKG0 | Y777 | Sugiyama | LARP1 KIAA0731 LARP | APEPstIARsLPttVPEsPNyRNtRtPRtPRtPQLKDSSQT |
| Q6S8J3 | Y1062 | Sugiyama | POTEE A26C1A POTE2 | GGSILASLSTFQQMWISKQEyDEsGPsIVHRKCF_______ |
| Q6S8J3 | Y940 | Sugiyama | POTEE A26C1A POTE2 | ALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPEA |
| Q6UN15 | S492 | Sugiyama | FIP1L1 FIP1 RHE | DRDRDRERERTRERERERDHsPtPsVFNsDEERyRYREYAE |
| Q6UN15 | T494 | Sugiyama | FIP1L1 FIP1 RHE | DRDRERERTRERERERDHsPtPsVFNsDEERyRYREYAERG |
| Q71U36 | Y312 | Sugiyama | TUBA1A TUBA3 | tNACFEPANQMVKCDPRHGKyMACCLLyRGDVVPKDVNAAI |
| Q71U36 | Y432 | Sugiyama | TUBA1A TUBA3 | GMEEGEFSEAREDMAALEKDyEEVGVDsVEGEGEEEGEEy_ |
| Q71U36 | Y451 | Sugiyama | TUBA1A TUBA3 | DyEEVGVDsVEGEGEEEGEEy____________________ |
| Q7L2J0 | S216 | Sugiyama | MEPCE BCDIN3 | NLNSLLDEEVSRtLNAEtPKssPLPAKGRDPVEILIPKDIt |
| Q7L2J0 | S217 | Sugiyama | MEPCE BCDIN3 | LNSLLDEEVSRtLNAEtPKssPLPAKGRDPVEILIPKDItD |
| Q7L2J0 | T213 | Sugiyama | MEPCE BCDIN3 | DPLNLNSLLDEEVSRtLNAEtPKssPLPAKGRDPVEILIPK |
| Q7Z4S6 | S1212 | Sugiyama | KIF21A KIAA1708 KIF2 | GQEIGMNTETSGTSAREKELsPPPGLPSKIGsIsRQssLsE |
| Q86V81 | S239 | Sugiyama | ALYREF ALY BEF THOC4 | tRGGARGRGRGAGRNSKQQLsAEELDAQLDAyNARMDts__ |
| Q86W56 | Y832 | Sugiyama | PARG | DDWQRRCTEIVAIDALHFRRyLDQFVPEKMRRELNKAYCGF |
| Q8IWW6 | Y243 | Sugiyama | ARHGAP12 | sTEQIRAttPPNQGRPDsPVyANLQELKISQSALPPLPGSP |
| Q8IZ21 | S118 | Sugiyama | PHACTR4 PRO2963 | PSDAMLKNGHTTPIGNARsssPVQVEEEPVRLAsLRKAIPE |
| Q8N0Y7 | S134 | Sugiyama | PGAM4 PGAM3 | IWRRsyDVPPPPMEPDHPFysNIsKDRRYADLTEDQLPSYE |
| Q8N0Y7 | Y92 | Sugiyama | PGAM4 PGAM3 | DAIDQMWLPVVRTWRLNERHyGGLtGLNKAETAAKHGEAQV |
| Q8N5P1 | Y97 | Sugiyama | ZC3H8 ZC3HDC8 | sDNDICsQEsEDNFAKELQQyIQAREMANAAQPEESTKKEG |
| Q8N684 | S205 | Sugiyama | CPSF7 | IPPRAHsRDssDsADGRAtPsENLVPSSARVDKPPSVLPYF |
| Q8N684 | T203 | Sugiyama | CPSF7 | GGIPPRAHsRDssDsADGRAtPsENLVPSSARVDKPPSVLP |
| Q8N7H5 | Y136 | Sugiyama | PAF1 PD2 | tssKRSQQHAKVVPWMRKTEyISTEFNRYGIsNEKPEVKIG |
| Q8N7H5 | Y169 | Sugiyama | PAF1 PD2 | EKPEVKIGVSVKQQFTEEEIyKDRDSQITAIEKTFEDAQKS |
| Q8NDI1 | Y585 | Sugiyama | EHBP1 KIAA0903 NACSIN | TYKVGNYETDTNssVDQEKFyAELSDLKREPELQQPISGAV |
| Q8TC07 | S675 | Sugiyama | TBC1D15 | TSAFQSNALPTLSASGARNDsPtQIPVssDVCRLtPA____ |
| Q8TD19 | Y52 | Sugiyama | NEK9 KIAA1995 NEK8 NERCC | PSASQGPRAGGGAAEQEELHyIPIRVLGRGAFGEAtLyRRT |
| Q8WYP5 | Y1790 | Sugiyama | AHCTF1 ELYS TMBS62 MSTP108 | QSVRKKTRKAKEISEASENIySDVRGLsQNQQIPQNsVtPR |
| Q969T4 | Y91 | Sugiyama | UBE2E3 UBCE4 UBCH9 | AEITLDPPPNCSAGPKGDNIyEWRSTILGPPGSVYEGGVFF |
| Q96D46 | Y459 | Sugiyama | NMD3 CGI-07 | YQDFLEDLEEDEAIRKNVNIyRDsAIPVEsDtDDEGAPRIS |
| Q96EU6 | Y138 | Sugiyama | RRP36 C6orf153 HSPC253 | RDPRFDDLSGEYNPEVFDKtyQFLNDIRAKEKELVKKQLKK |
| Q96G46 | T273 | Sugiyama | DUS3L | GAPRQENCGAQQVPAGPGtstPPssPVRtCGPLtDEDVVRL |
| Q96LR5 | Y85 | Sugiyama | UBE2E2 UBCH8 | AEITLDPPPNCSAGPKGDNIyEWRSTILGPPGSVYEGGVFF |
| Q96MU7 | S308 | Sugiyama | YTHDC1 KIAA1966 YT521 | GSGTDGsDEKKKERKRARGIsPIVFDRsGssAsESYAGsEK |
| Q96P70 | Y889 | Sugiyama | IPO9 IMP9 KIAA1192 RANBP9 HSPC273 | HGINADDKRLQDIRVKGEEIysMDEGIRTRSKSAKNPERWT |
| Q96S44 | T8 | Sugiyama | TP53RK C20orf64 PRPK | _____________MAAARAttPADGEEPAPEAEALAAARER |
| Q99613 | Y881 | Sugiyama | EIF3C EIF3S8 | EKLGsLVENNERVFDHKQGtyGGyFRDQKDGYRKNEGYMRR |
| Q99733 | Y95 | Sugiyama | NAP1L4 NAP2 | VRCAHIEAKFyEEVHDLERKyAALyQPLFDKRREFItGDVE |
| Q99733 | Y99 | Sugiyama | NAP1L4 NAP2 | HIEAKFyEEVHDLERKyAALyQPLFDKRREFItGDVEPtDA |
| Q99848 | Y265 | Sugiyama | EBNA1BP2 EBP2 | NQKFGFGGKKKGSKWNtREsyDDVssFRAKTAHGRGLKRPG |
| Q99961 | Y57 | Sugiyama | SH3GL1 CNSA1 SH3D2B | EKKVDVTSKAVTEVLARTIEyLQPNPAsRAKLTMLNTVSKI |
| Q99962 | Y57 | Sugiyama | SH3GL2 CNSA2 SH3D2A | ERKVDVTSRAVMEIMTKTIEyLQPNPAsRAKLSMINTMsKI |
| Q9BPX3 | Y929 | Sugiyama | NCAPG CAPG NYMEL3 | QDATLTTTTFQNEDEKNKEVyMtPLRGVKATQASKSTQLKT |
| Q9BQE3 | Y312 | Sugiyama | TUBA1C TUBA6 | TNACFEPANQMVKCDPRHGKyMACCLLyRGDVVPKDVNAAI |
| Q9BQE3 | Y432 | Sugiyama | TUBA1C TUBA6 | GMEEGEFSEAREDMAALEKDyEEVGADsADGEDEGEEy___ |
| Q9BRK5 | Y342 | Sugiyama | SDF4 CAB45 PSEC0034 | MIAVADENQNHHLEPEEVLKysEFFTGSKLVDYARsVHEEF |
| Q9BVA1 | T107 | Sugiyama | TUBB2B | PDNFVFGQsGAGNNWAKGHytEGAELVDsVLDVVRKESESC |
| Q9BVP2 | Y548 | Sugiyama | GNL3 E2IG3 NS | RSFILDKIIEEDDAyDFSTDyV___________________ |
| Q9BYX7 | Y240 | Sugiyama | POTEKP ACTBL3 FKSG30 | ALDSEQEMAMAASSSSVEKsyELPDGQVItIGNERFRCPEA |
| Q9BYX7 | Y362 | Sugiyama | POTEKP ACTBL3 FKSG30 | GGSILASLSTFQQMWISKQEyDEsGPsIVHRKCF_______ |
| Q9C0C2 | S1103 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | KRGWVGEFSLSVGPQREAAFsPGQQDWsRDFCIEASERsyQ |
| Q9C0C2 | S672 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | TLARAETtQARtEAQDLCRAsPEPPGPEsSSRWLDDLLAsP |
| Q9C0C9 | S87 | Sugiyama | UBE2O KIAA1734 | SGRYRGsVHFGLVRLIHGEDsDsEGEEEGRGssGCSEAGGA |
| Q9C0C9 | S89 | Sugiyama | UBE2O KIAA1734 | RYRGsVHFGLVRLIHGEDsDsEGEEEGRGssGCSEAGGAGH |
| Q9H1E3 | S144 | Sugiyama | NUCKS1 NUCKS JC7 | PFQEKDsGsDEDFLMEDDDDsDyGSsKKKNKKMVKKSKPER |
| Q9H1E3 | Y146 | Sugiyama | NUCKS1 NUCKS JC7 | QEKDsGsDEDFLMEDDDDsDyGSsKKKNKKMVKKSKPERKE |
| Q9H2U1 | Y169 | Sugiyama | DHX36 DDX36 KIAA1488 MLEL1 RHAU | NQEKKMFRIRNRsyIDRDsEyLLQENEPDGtLDQKLLEDLQ |
| Q9H4A3 | S1261 | Sugiyama | WNK1 HSN2 KDP KIAA0344 PRKWNK1 | GIPTSSLTQVVHSAGRRFIVsPVPEsRLRESKVFPSEITDT |
| Q9H6F5 | S91 | Sugiyama | CCDC86 CYCLON | RLQQGAGLEsPQGQPEPGAAsPQRQQDLHLEsPQRQPEysP |
| Q9H6F5 | Y109 | Sugiyama | CCDC86 CYCLON | AAsPQRQQDLHLEsPQRQPEysPEsPRCQPKPSEEAPKCsQ |
| Q9H6Z4 | T363 | Sugiyama | RANBP3 | DANRENAAAEsGsEsssQEAtPEKESLAEsAAAyTKATARK |
| Q9H7D7 | S121 | Sugiyama | WDR26 CDW2 MIP2 PRO0852 | ASSSLATPELGSSLKKKKRLsQsDEDVIRLIGQHLNGLGLN |
| Q9H7N4 | S498 | Sugiyama | SCAF1 SFRS19 SRA1 | GGLDLRRKILTQRRERyRQRsPsPAPAPAPAAAAGPPTRKK |
| Q9H7N4 | S500 | Sugiyama | SCAF1 SFRS19 SRA1 | LDLRRKILTQRRERyRQRsPsPAPAPAPAAAAGPPTRKKSR |
| Q9H814 | Y57 | Sugiyama | PHAX RNUXA | GDsAMRAFQNTAtACAPVSHyRAVESVDSSEESFSDSDDDS |
| Q9HAP6 | Y118 | Sugiyama | LIN7B MALS2 VELI2 UNQ3116/PRO10200 | KTDEGLGFNIMGGKEQNsPIyIsRVIPGGVADRHGGLKRGD |
| Q9HB07 | Y189 | Sugiyama | MYG1 C12orf10 | VEEVDAVDNGISQWAEGEPRyALttTLsARVARLNPTWNHP |
| Q9NPI6 | S525 | Sugiyama | DCP1A SMIF | SVFQQTVTRSSDLERKAssPsPLtIGtPEsQRKPSIILSKs |
| Q9NPQ8 | T441 | Sugiyama | RIC8A | AARGLMAGGRPEGQysEDEDtDtDEyKEAKAsINPVTGRVE |
| Q9NUP9 | Y118 | Sugiyama | LIN7C MALS3 VELI3 | KTEEGLGFNIMGGKEQNsPIyIsRIIPGGIADRHGGLKRGD |
| Q9NWB6 | S77 | Sugiyama | ARGLU1 | RsRstNTAVSRRERDRERAssPPDRIDIFGRTVSKRSSLDE |
| Q9NZB2 | T413 | Sugiyama | FAM120A C9orf10 KIAA0183 OSSA | yPysLSEPAPLTLDTSGKNLtEQNsysNIPHEGKHtPLyER |
| Q9NZB2 | Y418 | Sugiyama | FAM120A C9orf10 KIAA0183 OSSA | SEPAPLTLDTSGKNLtEQNsysNIPHEGKHtPLyERssPIN |
| Q9UBR2 | Y76 | Sugiyama | CTSZ | YLSPADLPKSWDWRNVDGVNyAsItRNQHIPQYCGSCWAHA |
| Q9UGV2 | S333 | Sugiyama | NDRG3 | MGYIPSASMTRLARsRtHstsssLGsGEsPFsRsVtsNQsD |
| Q9UI15 | T190 | Sugiyama | TAGLN3 NP25 | GQNVIGLQMGSNKGAsQAGMtGyGMPRQIM___________ |
| Q9UI15 | Y192 | Sugiyama | TAGLN3 NP25 | NVIGLQMGSNKGAsQAGMtGyGMPRQIM_____________ |
| Q9UII2 | Y58 | Sugiyama | ATP5IF1 ATPI ATPIF1 | GsIREAGGAFGKREQAEEERyFRAQsREQLAALKKHHEEEI |
| Q9UK59 | Y533 | Sugiyama | DBR1 | LsDEHEPEQRKKIKRRNQAIyAAVDDDDDDAA_________ |
| Q9UKK9 | Y16 | Sugiyama | NUDT5 NUDIX5 HSPC115 | _____MEsQEPtEssQNGKQyIISEELIsEGKWVKLEKTTY |
| Q9UMX5 | Y65 | Sugiyama | NENF CIR2 SPUF | RLFtEEELARYGGEEEDQPIyLAVKGVVFDVtSGKEFYGRG |
| Q9UNX3 | T8 | Sugiyama | RPL26L1 RPL26P1 | _____________MKFNPFVtsDRsKNRKRHFNAPSHVRRK |
| Q9UQ35 | S1103 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | sPsLQSKSQTsPKGGRsRsssPVtELAsRsPIRQDRGEFsA |
| Q9UQ35 | S1648 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | APRALPRRSRSGSSSKGRGPsPEGssstEssPEHPPKSRTA |
| Q9UQ35 | S2132 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | SRMsCFsRPsMsPtPLDRCRsPGMLEPLGssRtPMsVLQQA |
| Q9UQ35 | S2398 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | ANLtsPRVPLsAyERVsGRtsPPLLDRARsRtPPsAPsQsR |
| Q9UQ35 | S876 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | tsPQANEQsVtPQRRsCFEssPDPELKsRtPsRHsCsGssP |
| Q9Y266 | T145 | Sugiyama | NUDC | AENHEAQLKNGsLDsPGKQDtEEDEEEDEKDKGKLKPNLGN |
| Q9Y2T7 | Y107 | Sugiyama | YBX2 CSDA3 MSY2 | KPVLAIQVLGTVKWFNVRNGyGFINRNDtKEDVFVHQtAIK |
| Q9Y2U5 | S164 | Sugiyama | MAP3K2 MAPKKK2 MEKK2 | FGAERKKRLsIIGPTSRDRssPPPGYIPDELHQVARNGSFT |
| Q9Y3D8 | Y31 | Sugiyama | AK6 CINAP AD-004 CGI-137 | TPGVGKTTLGKELASKSGLKyINVGDLAREEQLYDGYDEEY |
| Q9Y3U8 | Y53 | Sugiyama | RPL36 | LTKHTKFVRDMIREVCGFAPyERRAMELLKVSKDKRALKFI |
| Q9Y490 | Y1893 | Sugiyama | TLN1 KIAA1027 TLN | TKsNtsPEELGPLANQLTsDyGRLAsEAKPAAVAAENEEIG |
| Q9Y5S9 | S56 | Sugiyama | RBM8A RBM8 HSPC114 MDS014 | KGRGFGsEEGsRARMREDyDsVEQDGDEPGPQRSVEGWILF |
| Q9Y639 | S213 | Sugiyama | NPTN SDFR1 SDR1 | ATRKNASNMEYRINKPRAEDsGEyHCVyHFVsAPKANATIE |
| Q9Y639 | Y216 | Sugiyama | NPTN SDFR1 SDR1 | KNASNMEYRINKPRAEDsGEyHCVyHFVsAPKANATIEVKA |
| Q9Y639 | Y220 | Sugiyama | NPTN SDFR1 SDR1 | NMEYRINKPRAEDsGEyHCVyHFVsAPKANATIEVKAAPDI |
| Q9Y696 | Y244 | Sugiyama | CLIC4 | AysRDEFtNtCPsDKEVEIAysDVAKRLTK___________ |
Site Promiscuity
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Packaging Of Telomere Ends | R-HSA-171306 | 1.225686e-13 | 12.912 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 1.225686e-13 | 12.912 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 4.407585e-14 | 13.356 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 2.299272e-13 | 12.638 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 2.604583e-13 | 12.584 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 5.527800e-13 | 12.257 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 7.290835e-13 | 12.137 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 1.241118e-12 | 11.906 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 1.076583e-12 | 11.968 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 1.241118e-12 | 11.906 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 2.058131e-12 | 11.687 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 2.793432e-12 | 11.554 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 2.626455e-12 | 11.581 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 2.626455e-12 | 11.581 | 0 | 0 |
| Depurination | R-HSA-73927 | 3.332667e-12 | 11.477 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 5.280443e-12 | 11.277 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 5.280443e-12 | 11.277 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 5.941359e-12 | 11.226 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 6.596612e-12 | 11.181 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 1.015033e-11 | 10.994 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 1.015033e-11 | 10.994 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 1.250700e-11 | 10.903 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 1.419831e-11 | 10.848 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 1.875244e-11 | 10.727 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 1.875244e-11 | 10.727 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 1.974421e-11 | 10.705 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 2.282574e-11 | 10.642 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 2.983902e-11 | 10.525 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 3.344280e-11 | 10.476 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 5.016776e-11 | 10.300 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 4.995104e-11 | 10.301 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 5.778567e-11 | 10.238 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 6.889433e-11 | 10.162 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 6.728673e-11 | 10.172 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 8.188772e-11 | 10.087 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 8.188772e-11 | 10.087 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 9.704448e-11 | 10.013 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 1.861791e-10 | 9.730 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 2.176918e-10 | 9.662 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 2.539152e-10 | 9.595 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 3.430144e-10 | 9.465 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 4.887102e-10 | 9.311 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 4.887102e-10 | 9.311 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 6.096351e-10 | 9.215 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 6.364584e-10 | 9.196 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 7.002722e-10 | 9.155 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 1.049179e-09 | 8.979 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 1.087063e-09 | 8.964 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 1.196132e-09 | 8.922 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 1.196132e-09 | 8.922 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 1.361266e-09 | 8.866 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 1.508347e-09 | 8.821 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 1.754083e-09 | 8.756 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 2.245508e-09 | 8.649 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 2.856738e-09 | 8.544 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 3.612784e-09 | 8.442 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 4.054108e-09 | 8.392 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 4.054108e-09 | 8.392 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 4.543030e-09 | 8.343 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 6.341747e-09 | 8.198 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 8.852804e-09 | 8.053 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 9.720255e-09 | 8.012 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 1.261376e-08 | 7.899 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 1.194874e-08 | 7.923 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 1.681424e-08 | 7.774 | 1 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 2.298840e-08 | 7.638 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 2.298840e-08 | 7.638 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 2.428596e-08 | 7.615 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 3.147167e-08 | 7.502 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 2.868523e-08 | 7.542 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 3.151811e-08 | 7.501 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 3.399207e-08 | 7.469 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 3.447183e-08 | 7.463 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 4.021719e-08 | 7.396 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 4.510555e-08 | 7.346 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 4.510555e-08 | 7.346 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 4.994914e-08 | 7.301 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 6.344398e-08 | 7.198 | 1 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 7.547965e-08 | 7.122 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 9.096683e-08 | 7.041 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 1.328658e-07 | 6.877 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 1.717478e-07 | 6.765 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 2.099433e-07 | 6.678 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 2.432724e-07 | 6.614 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 2.616298e-07 | 6.582 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 3.063819e-07 | 6.514 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 3.182868e-07 | 6.497 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 3.572669e-07 | 6.447 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 3.583141e-07 | 6.446 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 3.730816e-07 | 6.428 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 3.730816e-07 | 6.428 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 3.730816e-07 | 6.428 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 5.607058e-07 | 6.251 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 1.124136e-06 | 5.949 | 0 | 0 |
| Immune System | R-HSA-168256 | 1.479397e-06 | 5.830 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 1.656321e-06 | 5.781 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 1.726935e-06 | 5.763 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 1.992514e-06 | 5.701 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 2.545380e-06 | 5.594 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 2.689597e-06 | 5.570 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 3.166138e-06 | 5.499 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 3.477854e-06 | 5.459 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 3.722299e-06 | 5.429 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 3.744213e-06 | 5.427 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 4.505174e-06 | 5.346 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 4.686037e-06 | 5.329 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 4.775484e-06 | 5.321 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 6.850649e-06 | 5.164 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 7.837143e-06 | 5.106 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 1.048149e-05 | 4.980 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 1.174117e-05 | 4.930 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 1.753452e-05 | 4.756 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 1.799674e-05 | 4.745 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 2.792272e-05 | 4.554 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 2.944145e-05 | 4.531 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 3.503077e-05 | 4.456 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 3.630807e-05 | 4.440 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 3.971805e-05 | 4.401 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 4.015582e-05 | 4.396 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 4.408167e-05 | 4.356 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 4.626157e-05 | 4.335 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 6.258361e-05 | 4.204 | 0 | 0 |
| Disease | R-HSA-1643685 | 6.351649e-05 | 4.197 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 7.870801e-05 | 4.104 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 9.211850e-05 | 4.036 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 9.957149e-05 | 4.002 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 1.243244e-04 | 3.905 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 1.309675e-04 | 3.883 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 1.374058e-04 | 3.862 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 1.600432e-04 | 3.796 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 1.617654e-04 | 3.791 | 0 | 0 |
| Activation of TRKA receptors | R-HSA-187015 | 1.782680e-04 | 3.749 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 2.104306e-04 | 3.677 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 2.784189e-04 | 3.555 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 2.980128e-04 | 3.526 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 3.826704e-04 | 3.417 | 0 | 0 |
| M Phase | R-HSA-68886 | 3.900543e-04 | 3.409 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 4.742667e-04 | 3.324 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 4.983852e-04 | 3.302 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 5.334565e-04 | 3.273 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 5.373385e-04 | 3.270 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 5.624680e-04 | 3.250 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 5.624680e-04 | 3.250 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 5.764550e-04 | 3.239 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 5.987990e-04 | 3.223 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 6.386888e-04 | 3.195 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 6.911111e-04 | 3.160 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 7.839188e-04 | 3.106 | 0 | 0 |
| RUNX3 regulates RUNX1-mediated transcription | R-HSA-8951911 | 8.620838e-04 | 3.064 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 9.773437e-04 | 3.010 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 1.017760e-03 | 2.992 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 1.017760e-03 | 2.992 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 1.075620e-03 | 2.968 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 1.140624e-03 | 2.943 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 1.140624e-03 | 2.943 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 1.143882e-03 | 2.942 | 0 | 0 |
| TRKA activation by NGF | R-HSA-187042 | 1.337704e-03 | 2.874 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 1.513979e-03 | 2.820 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 1.513979e-03 | 2.820 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 1.513979e-03 | 2.820 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 1.658739e-03 | 2.780 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 1.745501e-03 | 2.758 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 1.782862e-03 | 2.749 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 1.782862e-03 | 2.749 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 1.913003e-03 | 2.718 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 2.212075e-03 | 2.655 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 2.226168e-03 | 2.652 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 2.386527e-03 | 2.622 | 0 | 0 |
| IRS activation | R-HSA-74713 | 2.585860e-03 | 2.587 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 3.077855e-03 | 2.512 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 3.107559e-03 | 2.508 | 0 | 0 |
| NGF-independant TRKA activation | R-HSA-187024 | 3.354185e-03 | 2.474 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 3.406417e-03 | 2.468 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 3.406417e-03 | 2.468 | 0 | 0 |
| Interleukin-20 family signaling | R-HSA-8854691 | 3.755660e-03 | 2.425 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 4.697957e-03 | 2.328 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 4.745016e-03 | 2.324 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 5.001158e-03 | 2.301 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 5.169051e-03 | 2.287 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 5.169051e-03 | 2.287 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 5.169051e-03 | 2.287 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 5.641461e-03 | 2.249 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 5.825449e-03 | 2.235 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 6.211578e-03 | 2.207 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 6.211578e-03 | 2.207 | 0 | 0 |
| Interleukin-23 signaling | R-HSA-9020933 | 6.211578e-03 | 2.207 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 6.211578e-03 | 2.207 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 6.775017e-03 | 2.169 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 8.557015e-03 | 2.068 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 8.557015e-03 | 2.068 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 8.794607e-03 | 2.056 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 8.557015e-03 | 2.068 | 0 | 0 |
| Interleukin-27 signaling | R-HSA-9020956 | 8.557015e-03 | 2.068 | 0 | 0 |
| MAPK1 (ERK2) activation | R-HSA-112411 | 7.341542e-03 | 2.134 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 8.557015e-03 | 2.068 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 8.709935e-03 | 2.060 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 7.887448e-03 | 2.103 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 9.290575e-03 | 2.032 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 7.821837e-03 | 2.107 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 9.682760e-03 | 2.014 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 9.856097e-03 | 2.006 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 1.032966e-02 | 1.986 | 0 | 0 |
| Drug resistance of PDGFR mutants | R-HSA-9674415 | 1.050183e-02 | 1.979 | 0 | 0 |
| PDGFR mutants bind TKIs | R-HSA-9674428 | 1.050183e-02 | 1.979 | 0 | 0 |
| Sorafenib-resistant PDGFR mutants | R-HSA-9674404 | 1.050183e-02 | 1.979 | 0 | 0 |
| Sunitinib-resistant PDGFR mutants | R-HSA-9674401 | 1.050183e-02 | 1.979 | 0 | 0 |
| Regorafenib-resistant PDGFR mutants | R-HSA-9674403 | 1.050183e-02 | 1.979 | 0 | 0 |
| Imatinib-resistant PDGFR mutants | R-HSA-9674396 | 1.050183e-02 | 1.979 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 1.100110e-02 | 1.959 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 1.123692e-02 | 1.949 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 1.123692e-02 | 1.949 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 1.147541e-02 | 1.940 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 1.177195e-02 | 1.929 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 1.201009e-02 | 1.920 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 1.241315e-02 | 1.906 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 1.269764e-02 | 1.896 | 0 | 0 |
| Interleukin-35 Signalling | R-HSA-8984722 | 1.269764e-02 | 1.896 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 1.269764e-02 | 1.896 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 1.317204e-02 | 1.880 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 1.423646e-02 | 1.847 | 0 | 0 |
| IL-6-type cytokine receptor ligand interactions | R-HSA-6788467 | 1.423646e-02 | 1.847 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 1.555287e-02 | 1.808 | 0 | 0 |
| Prolactin receptor signaling | R-HSA-1170546 | 1.585158e-02 | 1.800 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 1.754127e-02 | 1.756 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 1.760554e-02 | 1.754 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 1.816986e-02 | 1.741 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 1.850511e-02 | 1.733 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 1.930378e-02 | 1.714 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 1.986780e-02 | 1.702 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 2.004216e-02 | 1.698 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 2.004216e-02 | 1.698 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 2.004216e-02 | 1.698 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 2.004216e-02 | 1.698 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 2.004216e-02 | 1.698 | 0 | 0 |
| Drug-mediated inhibition of MET activation | R-HSA-9734091 | 2.089402e-02 | 1.680 | 0 | 0 |
| SARS-CoV-1 targets PDZ proteins in cell-cell junction | R-HSA-9692912 | 2.089402e-02 | 1.680 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 2.363162e-02 | 1.627 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 2.501148e-02 | 1.602 | 0 | 0 |
| Nephron development | R-HSA-9831926 | 2.501148e-02 | 1.602 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 2.501148e-02 | 1.602 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 2.534686e-02 | 1.596 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 2.692752e-02 | 1.570 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 2.706040e-02 | 1.568 | 0 | 0 |
| NTRK3 as a dependence receptor | R-HSA-9603505 | 3.117770e-02 | 1.506 | 0 | 0 |
| NTF3 activates NTRK2 (TRKB) signaling | R-HSA-9025046 | 4.135400e-02 | 1.383 | 0 | 0 |
| BDNF activates NTRK2 (TRKB) signaling | R-HSA-9024909 | 4.135400e-02 | 1.383 | 0 | 0 |
| NTF4 activates NTRK2 (TRKB) signaling | R-HSA-9026357 | 4.135400e-02 | 1.383 | 0 | 0 |
| NTF3 activates NTRK3 signaling | R-HSA-9034013 | 4.135400e-02 | 1.383 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 2.915038e-02 | 1.535 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 3.354151e-02 | 1.474 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 4.057451e-02 | 1.392 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 3.216993e-02 | 1.493 | 0 | 0 |
| Transport of connexins along the secretory pathway | R-HSA-190827 | 3.117770e-02 | 1.506 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 4.135400e-02 | 1.383 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 3.131519e-02 | 1.504 | 0 | 0 |
| Oligomerization of connexins into connexons | R-HSA-190704 | 3.117770e-02 | 1.506 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 4.057451e-02 | 1.392 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 4.169364e-02 | 1.380 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 4.169364e-02 | 1.380 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 3.582782e-02 | 1.446 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 3.371200e-02 | 1.472 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 2.831670e-02 | 1.548 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 3.354151e-02 | 1.474 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 3.820504e-02 | 1.418 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 4.291364e-02 | 1.367 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 4.303197e-02 | 1.366 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 4.303197e-02 | 1.366 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 4.303197e-02 | 1.366 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 4.303197e-02 | 1.366 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 4.548670e-02 | 1.342 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 4.554362e-02 | 1.342 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 4.554362e-02 | 1.342 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 4.554362e-02 | 1.342 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 4.685227e-02 | 1.329 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 4.770941e-02 | 1.321 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 4.810805e-02 | 1.318 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 4.900252e-02 | 1.310 | 0 | 0 |
| PLC-gamma1 signalling | R-HSA-167021 | 5.142402e-02 | 1.289 | 0 | 0 |
| Activated NTRK3 signals through PLCG1 | R-HSA-9034793 | 5.142402e-02 | 1.289 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 5.142402e-02 | 1.289 | 0 | 0 |
| Signalling to STAT3 | R-HSA-198745 | 5.142402e-02 | 1.289 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 5.142402e-02 | 1.289 | 0 | 0 |
| STAT6-mediated induction of chemokines | R-HSA-3249367 | 5.142402e-02 | 1.289 | 0 | 0 |
| MET activates STAT3 | R-HSA-8875791 | 5.142402e-02 | 1.289 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 5.210723e-02 | 1.283 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 5.583821e-02 | 1.253 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 5.597492e-02 | 1.252 | 0 | 0 |
| Activated NTRK2 signals through PLCG1 | R-HSA-9026527 | 6.138889e-02 | 1.212 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 6.138889e-02 | 1.212 | 0 | 0 |
| RUNX2 regulates genes involved in differentiation of myeloid cells | R-HSA-8941333 | 6.138889e-02 | 1.212 | 0 | 0 |
| FLT3 signaling through SRC family kinases | R-HSA-9706374 | 6.138889e-02 | 1.212 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 6.452802e-02 | 1.190 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 6.721824e-02 | 1.173 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 7.036407e-02 | 1.153 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 7.036407e-02 | 1.153 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in interleukin signaling | R-HSA-8939247 | 7.124968e-02 | 1.147 | 0 | 0 |
| NTRK2 activates RAC1 | R-HSA-9032759 | 7.124968e-02 | 1.147 | 0 | 0 |
| Reelin signalling pathway | R-HSA-8866376 | 7.124968e-02 | 1.147 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 7.334456e-02 | 1.135 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 7.636510e-02 | 1.117 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 7.645150e-02 | 1.117 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 7.654870e-02 | 1.116 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 7.942455e-02 | 1.100 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 8.100748e-02 | 1.091 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 8.100748e-02 | 1.091 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 8.100748e-02 | 1.091 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 8.100748e-02 | 1.091 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 8.100748e-02 | 1.091 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 8.100748e-02 | 1.091 | 0 | 0 |
| Epithelial-Mesenchymal Transition (EMT) during gastrulation | R-HSA-9758919 | 8.100748e-02 | 1.091 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 8.147446e-02 | 1.089 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in WNT signaling | R-HSA-8939256 | 9.066336e-02 | 1.043 | 0 | 0 |
| STAT5 Activation | R-HSA-9645135 | 9.066336e-02 | 1.043 | 0 | 0 |
| Activated NTRK2 signals through CDK5 | R-HSA-9032845 | 1.002184e-01 | 0.999 | 0 | 0 |
| MET activates PI3K/AKT signaling | R-HSA-8851907 | 1.002184e-01 | 0.999 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 1.002184e-01 | 0.999 | 0 | 0 |
| Activated NTRK2 signals through FYN | R-HSA-9032500 | 1.096736e-01 | 0.960 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 1.096736e-01 | 0.960 | 0 | 0 |
| Activated NTRK2 signals through PI3K | R-HSA-9028335 | 1.096736e-01 | 0.960 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 1.096736e-01 | 0.960 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 1.096736e-01 | 0.960 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 1.190300e-01 | 0.924 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 1.190300e-01 | 0.924 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 1.282887e-01 | 0.892 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 1.374506e-01 | 0.862 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 1.465168e-01 | 0.834 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 1.554882e-01 | 0.808 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 1.554882e-01 | 0.808 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 1.554882e-01 | 0.808 | 0 | 0 |
| RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) | R-HSA-8877330 | 1.643659e-01 | 0.784 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 8.252175e-02 | 1.083 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 9.853571e-02 | 1.006 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 1.327940e-01 | 0.877 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 9.009716e-02 | 1.045 | 0 | 0 |
| RUNX1 regulates estrogen receptor mediated transcription | R-HSA-8931987 | 1.002184e-01 | 0.999 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 1.465168e-01 | 0.834 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 1.050166e-01 | 0.979 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 9.526610e-02 | 1.021 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 1.282887e-01 | 0.892 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 1.374506e-01 | 0.862 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 9.437882e-02 | 1.025 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of keratinocytes | R-HSA-8939242 | 1.096736e-01 | 0.960 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 1.222448e-01 | 0.913 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 1.643659e-01 | 0.784 | 0 | 0 |
| MET Receptor Activation | R-HSA-6806942 | 9.066336e-02 | 1.043 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 1.554882e-01 | 0.808 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 1.257378e-01 | 0.901 | 0 | 0 |
| Conjugation of benzoate with glycine | R-HSA-177135 | 1.374506e-01 | 0.862 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 1.554882e-01 | 0.808 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 1.554882e-01 | 0.808 | 0 | 0 |
| Conjugation of salicylate with glycine | R-HSA-177128 | 1.554882e-01 | 0.808 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 1.508049e-01 | 0.822 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.646913e-02 | 1.016 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 1.183711e-01 | 0.927 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 1.567493e-01 | 0.805 | 0 | 0 |
| Interleukin-21 signaling | R-HSA-9020958 | 1.190300e-01 | 0.924 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 1.643659e-01 | 0.784 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 8.754632e-02 | 1.058 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 1.085285e-01 | 0.964 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 1.443613e-01 | 0.841 | 0 | 0 |
| VLDL clearance | R-HSA-8964046 | 1.002184e-01 | 0.999 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 1.374506e-01 | 0.862 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 1.229573e-01 | 0.910 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 1.363555e-01 | 0.865 | 0 | 0 |
| Interleukin-9 signaling | R-HSA-8985947 | 1.096736e-01 | 0.960 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 1.051679e-01 | 0.978 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 1.222448e-01 | 0.913 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 1.554882e-01 | 0.808 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 8.882500e-02 | 1.051 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 9.526610e-02 | 1.021 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 9.202885e-02 | 1.036 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 1.187765e-01 | 0.925 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 1.374696e-01 | 0.862 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 1.554882e-01 | 0.808 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 1.643659e-01 | 0.784 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 9.285224e-02 | 1.032 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 1.190300e-01 | 0.924 | 0 | 0 |
| Kinesins | R-HSA-983189 | 1.618330e-01 | 0.791 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 8.882500e-02 | 1.051 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 1.395015e-01 | 0.855 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 1.085285e-01 | 0.964 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 1.471637e-01 | 0.832 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 1.505813e-01 | 0.822 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 1.252745e-01 | 0.902 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 9.202885e-02 | 1.036 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 1.327940e-01 | 0.877 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 9.526610e-02 | 1.021 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 1.051679e-01 | 0.978 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 1.051679e-01 | 0.978 | 0 | 0 |
| Dissolution of Fibrin Clot | R-HSA-75205 | 1.374506e-01 | 0.862 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 9.693803e-02 | 1.014 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 1.242819e-01 | 0.906 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 1.655413e-01 | 0.781 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 1.655413e-01 | 0.781 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 1.720306e-01 | 0.764 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 1.730020e-01 | 0.762 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 1.731508e-01 | 0.762 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 1.731508e-01 | 0.762 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 1.731508e-01 | 0.762 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 1.767530e-01 | 0.753 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 1.767530e-01 | 0.753 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 1.772169e-01 | 0.751 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 1.805168e-01 | 0.743 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 1.805168e-01 | 0.743 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 1.811517e-01 | 0.742 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 1.818439e-01 | 0.740 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 1.818439e-01 | 0.740 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 1.818439e-01 | 0.740 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 1.818439e-01 | 0.740 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 1.818439e-01 | 0.740 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 1.818439e-01 | 0.740 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 1.818439e-01 | 0.740 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 1.877169e-01 | 0.726 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 1.880800e-01 | 0.726 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 1.904462e-01 | 0.720 | 0 | 0 |
| Defective GALNT3 causes HFTC | R-HSA-5083625 | 1.904462e-01 | 0.720 | 0 | 0 |
| Defective GALNT12 causes CRCS1 | R-HSA-5083636 | 1.904462e-01 | 0.720 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 1.904462e-01 | 0.720 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 1.904462e-01 | 0.720 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 1.904462e-01 | 0.720 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 1.956866e-01 | 0.708 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 1.968015e-01 | 0.706 | 0 | 0 |
| Antigen processing: Ub, ATP-independent proteasomal degradation | R-HSA-9912633 | 1.989585e-01 | 0.701 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 1.989585e-01 | 0.701 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 1.989585e-01 | 0.701 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 1.989585e-01 | 0.701 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 2.021271e-01 | 0.694 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 2.064623e-01 | 0.685 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 2.071666e-01 | 0.684 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 2.073818e-01 | 0.683 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 2.073818e-01 | 0.683 | 0 | 0 |
| Defective C1GALT1C1 causes TNPS | R-HSA-5083632 | 2.073818e-01 | 0.683 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 2.073818e-01 | 0.683 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 2.073818e-01 | 0.683 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 2.102889e-01 | 0.677 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 2.110095e-01 | 0.676 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 2.152175e-01 | 0.667 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 2.157171e-01 | 0.666 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 2.157171e-01 | 0.666 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 2.157171e-01 | 0.666 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 2.157171e-01 | 0.666 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 2.225789e-01 | 0.653 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 2.239652e-01 | 0.650 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 2.239652e-01 | 0.650 | 0 | 0 |
| Conjugation of carboxylic acids | R-HSA-159424 | 2.239652e-01 | 0.650 | 0 | 0 |
| Amino Acid conjugation | R-HSA-156587 | 2.239652e-01 | 0.650 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 2.239652e-01 | 0.650 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 2.239652e-01 | 0.650 | 0 | 0 |
| Formation of ATP by chemiosmotic coupling | R-HSA-163210 | 2.321271e-01 | 0.634 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 2.321271e-01 | 0.634 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 2.402037e-01 | 0.619 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 2.458516e-01 | 0.609 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 2.481957e-01 | 0.605 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 2.561043e-01 | 0.592 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 2.561043e-01 | 0.592 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 2.561043e-01 | 0.592 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 2.639301e-01 | 0.579 | 0 | 0 |
| Termination of O-glycan biosynthesis | R-HSA-977068 | 2.639301e-01 | 0.579 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 2.639301e-01 | 0.579 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 2.639301e-01 | 0.579 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 2.648276e-01 | 0.577 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 2.676640e-01 | 0.572 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 2.696171e-01 | 0.569 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 2.716740e-01 | 0.566 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 2.716740e-01 | 0.566 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 2.716740e-01 | 0.566 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 2.716740e-01 | 0.566 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 2.731071e-01 | 0.564 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 2.764505e-01 | 0.558 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 2.793370e-01 | 0.554 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 2.793370e-01 | 0.554 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 2.847858e-01 | 0.545 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 2.869198e-01 | 0.542 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 2.882943e-01 | 0.540 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 2.925627e-01 | 0.534 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 2.944233e-01 | 0.531 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 2.944233e-01 | 0.531 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 2.944233e-01 | 0.531 | 0 | 0 |
| Insulin receptor recycling | R-HSA-77387 | 3.018483e-01 | 0.520 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 3.091956e-01 | 0.510 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 3.091956e-01 | 0.510 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 3.091956e-01 | 0.510 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 3.119511e-01 | 0.506 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 3.119511e-01 | 0.506 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 3.164660e-01 | 0.500 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 3.164660e-01 | 0.500 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 3.164660e-01 | 0.500 | 1 | 1 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 3.164660e-01 | 0.500 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 3.235333e-01 | 0.490 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 3.236604e-01 | 0.490 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 3.236604e-01 | 0.490 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 3.236604e-01 | 0.490 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 3.236604e-01 | 0.490 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 3.236604e-01 | 0.490 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 3.306588e-01 | 0.481 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 3.306588e-01 | 0.481 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 3.307794e-01 | 0.480 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 3.307794e-01 | 0.480 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 3.307794e-01 | 0.480 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 3.312280e-01 | 0.480 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 3.378240e-01 | 0.471 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 3.378240e-01 | 0.471 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 3.378240e-01 | 0.471 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 3.447949e-01 | 0.462 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 3.447949e-01 | 0.462 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 3.447949e-01 | 0.462 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 3.516928e-01 | 0.454 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 3.516928e-01 | 0.454 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 3.516928e-01 | 0.454 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 3.516928e-01 | 0.454 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 3.516928e-01 | 0.454 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 3.541577e-01 | 0.451 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 3.585185e-01 | 0.445 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 3.585185e-01 | 0.445 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 3.585185e-01 | 0.445 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 3.617419e-01 | 0.442 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 3.619008e-01 | 0.441 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 3.652727e-01 | 0.437 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 3.652727e-01 | 0.437 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 3.652727e-01 | 0.437 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 3.652727e-01 | 0.437 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 3.719563e-01 | 0.430 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 3.719563e-01 | 0.430 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 3.719563e-01 | 0.430 | 0 | 0 |
| SLC-mediated transport of organic cations | R-HSA-549127 | 3.719563e-01 | 0.430 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 3.790217e-01 | 0.421 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 3.851142e-01 | 0.414 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 3.851142e-01 | 0.414 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 3.851142e-01 | 0.414 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 3.851142e-01 | 0.414 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 3.851142e-01 | 0.414 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 3.851142e-01 | 0.414 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 3.915900e-01 | 0.407 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 3.915900e-01 | 0.407 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 3.915900e-01 | 0.407 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 3.915900e-01 | 0.407 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 3.915900e-01 | 0.407 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 3.915900e-01 | 0.407 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 3.979981e-01 | 0.400 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 3.979981e-01 | 0.400 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 3.979981e-01 | 0.400 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 3.979981e-01 | 0.400 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 4.043390e-01 | 0.393 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 4.043390e-01 | 0.393 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 4.043390e-01 | 0.393 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 4.043390e-01 | 0.393 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 4.043390e-01 | 0.393 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 4.043390e-01 | 0.393 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 4.043390e-01 | 0.393 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 4.043390e-01 | 0.393 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 4.101545e-01 | 0.387 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 4.168223e-01 | 0.380 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 4.168223e-01 | 0.380 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 4.229661e-01 | 0.374 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 4.229661e-01 | 0.374 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 4.229661e-01 | 0.374 | 0 | 0 |
| Methylation | R-HSA-156581 | 4.229661e-01 | 0.374 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 4.229661e-01 | 0.374 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 4.229661e-01 | 0.374 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 4.283044e-01 | 0.368 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 4.290456e-01 | 0.367 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 4.290456e-01 | 0.367 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 4.290456e-01 | 0.367 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 4.290456e-01 | 0.367 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 4.290456e-01 | 0.367 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 4.290456e-01 | 0.367 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 4.290456e-01 | 0.367 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 4.350613e-01 | 0.361 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 4.350613e-01 | 0.361 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 4.350613e-01 | 0.361 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 4.410141e-01 | 0.356 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 4.410141e-01 | 0.356 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 4.410141e-01 | 0.356 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 4.469045e-01 | 0.350 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 4.527332e-01 | 0.344 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 4.527332e-01 | 0.344 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 4.585008e-01 | 0.339 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 4.585008e-01 | 0.339 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 4.642080e-01 | 0.333 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 4.642080e-01 | 0.333 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 4.642080e-01 | 0.333 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 4.642080e-01 | 0.333 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 4.698553e-01 | 0.328 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 4.698553e-01 | 0.328 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 4.698553e-01 | 0.328 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 4.698553e-01 | 0.328 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 4.754435e-01 | 0.323 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 4.754435e-01 | 0.323 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 4.754435e-01 | 0.323 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 4.754435e-01 | 0.323 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 4.809732e-01 | 0.318 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 4.809732e-01 | 0.318 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 4.809732e-01 | 0.318 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 4.864449e-01 | 0.313 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 4.864449e-01 | 0.313 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 4.877082e-01 | 0.312 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 4.910832e-01 | 0.309 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 4.918592e-01 | 0.308 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 4.918592e-01 | 0.308 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 4.918592e-01 | 0.308 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 4.918592e-01 | 0.308 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 4.972168e-01 | 0.303 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 4.972168e-01 | 0.303 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 5.025182e-01 | 0.299 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 5.025182e-01 | 0.299 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 5.044433e-01 | 0.297 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 5.077480e-01 | 0.294 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 5.077641e-01 | 0.294 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 5.077641e-01 | 0.294 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 5.077641e-01 | 0.294 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 5.103137e-01 | 0.292 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 5.110385e-01 | 0.292 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 5.129550e-01 | 0.290 | 1 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 5.129550e-01 | 0.290 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 5.129550e-01 | 0.290 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 5.129550e-01 | 0.290 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 5.180914e-01 | 0.286 | 0 | 0 |
| Endogenous sterols | R-HSA-211976 | 5.180914e-01 | 0.286 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 5.180914e-01 | 0.286 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 5.231740e-01 | 0.281 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 5.231740e-01 | 0.281 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 5.231740e-01 | 0.281 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 5.231740e-01 | 0.281 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 5.231740e-01 | 0.281 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 5.272745e-01 | 0.278 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 5.282033e-01 | 0.277 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 5.282033e-01 | 0.277 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 5.282033e-01 | 0.277 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 5.282033e-01 | 0.277 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 5.331798e-01 | 0.273 | 0 | 0 |
| Xenobiotics | R-HSA-211981 | 5.331798e-01 | 0.273 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 5.368411e-01 | 0.270 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 5.400005e-01 | 0.268 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 5.429769e-01 | 0.265 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 5.477986e-01 | 0.261 | 0 | 0 |
| O-linked glycosylation of mucins | R-HSA-913709 | 5.525696e-01 | 0.258 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 5.525696e-01 | 0.258 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 5.525696e-01 | 0.258 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 5.619621e-01 | 0.250 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 5.619621e-01 | 0.250 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 5.619621e-01 | 0.250 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 5.619621e-01 | 0.250 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 5.665846e-01 | 0.247 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 5.665846e-01 | 0.247 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 5.665846e-01 | 0.247 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 5.665846e-01 | 0.247 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 5.711585e-01 | 0.243 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 5.711585e-01 | 0.243 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 5.711585e-01 | 0.243 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 5.756845e-01 | 0.240 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 5.756845e-01 | 0.240 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 5.756845e-01 | 0.240 | 0 | 0 |
| Aspirin ADME | R-HSA-9749641 | 5.756845e-01 | 0.240 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 5.801630e-01 | 0.236 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 5.801630e-01 | 0.236 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 5.801630e-01 | 0.236 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 5.801630e-01 | 0.236 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 5.845945e-01 | 0.233 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 5.845945e-01 | 0.233 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 5.933185e-01 | 0.227 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 5.976120e-01 | 0.224 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 5.976120e-01 | 0.224 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 5.976120e-01 | 0.224 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 5.976120e-01 | 0.224 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 5.976120e-01 | 0.224 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 5.976120e-01 | 0.224 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 6.060641e-01 | 0.217 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 6.184126e-01 | 0.209 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 6.224426e-01 | 0.206 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 6.224426e-01 | 0.206 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 6.264303e-01 | 0.203 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 6.264303e-01 | 0.203 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 6.303761e-01 | 0.200 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 6.303761e-01 | 0.200 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 6.342805e-01 | 0.198 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 6.381439e-01 | 0.195 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 6.384691e-01 | 0.195 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 6.419668e-01 | 0.192 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 6.437175e-01 | 0.191 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 6.457494e-01 | 0.190 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 6.494924e-01 | 0.187 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 6.494924e-01 | 0.187 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 6.531960e-01 | 0.185 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 6.568607e-01 | 0.183 | 0 | 0 |
| Protein folding | R-HSA-391251 | 6.604869e-01 | 0.180 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 6.604869e-01 | 0.180 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 6.676255e-01 | 0.175 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 6.711386e-01 | 0.173 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 6.746148e-01 | 0.171 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 6.746148e-01 | 0.171 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 6.746148e-01 | 0.171 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 6.780544e-01 | 0.169 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 6.811870e-01 | 0.167 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 6.814580e-01 | 0.167 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 6.868782e-01 | 0.163 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 6.881581e-01 | 0.162 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 6.906229e-01 | 0.161 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 6.914554e-01 | 0.160 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 6.914554e-01 | 0.160 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 6.914554e-01 | 0.160 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 6.947180e-01 | 0.158 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 6.947180e-01 | 0.158 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 6.979464e-01 | 0.156 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 7.011408e-01 | 0.154 | 0 | 0 |
| Translation | R-HSA-72766 | 7.020503e-01 | 0.154 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 7.043016e-01 | 0.152 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 7.043016e-01 | 0.152 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 7.043472e-01 | 0.152 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 7.105239e-01 | 0.148 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 7.166160e-01 | 0.145 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 7.166160e-01 | 0.145 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 7.175645e-01 | 0.144 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 7.196141e-01 | 0.143 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 7.196141e-01 | 0.143 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 7.196141e-01 | 0.143 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 7.196141e-01 | 0.143 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 7.312944e-01 | 0.136 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 7.312944e-01 | 0.136 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 7.364620e-01 | 0.133 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 7.424909e-01 | 0.129 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 7.427041e-01 | 0.129 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 7.452168e-01 | 0.128 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 7.459763e-01 | 0.127 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 7.479140e-01 | 0.126 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 7.479140e-01 | 0.126 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 7.505828e-01 | 0.125 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 7.505828e-01 | 0.125 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 7.505828e-01 | 0.125 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 7.599839e-01 | 0.119 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 7.684941e-01 | 0.114 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 7.733725e-01 | 0.112 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 7.781488e-01 | 0.109 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 7.896561e-01 | 0.103 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 7.918854e-01 | 0.101 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 7.940911e-01 | 0.100 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 8.026841e-01 | 0.095 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 8.047761e-01 | 0.094 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 8.068460e-01 | 0.093 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 8.111802e-01 | 0.091 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 8.168727e-01 | 0.088 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 8.263819e-01 | 0.083 | 0 | 0 |
| S Phase | R-HSA-69242 | 8.282240e-01 | 0.082 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 8.299699e-01 | 0.081 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 8.318501e-01 | 0.080 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 8.354000e-01 | 0.078 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 8.388755e-01 | 0.076 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 8.405858e-01 | 0.075 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 8.405858e-01 | 0.075 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 8.422780e-01 | 0.075 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 8.439524e-01 | 0.074 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 8.439524e-01 | 0.074 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 8.456091e-01 | 0.073 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 8.488702e-01 | 0.071 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 8.551884e-01 | 0.068 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 8.551884e-01 | 0.068 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 8.597541e-01 | 0.066 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 8.656198e-01 | 0.063 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 8.759849e-01 | 0.058 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 8.766295e-01 | 0.057 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 8.779410e-01 | 0.057 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 8.842939e-01 | 0.053 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 8.870004e-01 | 0.052 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 8.891386e-01 | 0.051 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 8.903179e-01 | 0.050 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 8.914848e-01 | 0.050 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 8.949118e-01 | 0.048 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 8.962253e-01 | 0.048 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 9.045606e-01 | 0.044 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 9.187235e-01 | 0.037 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 9.195897e-01 | 0.036 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.229636e-01 | 0.035 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 9.284770e-01 | 0.032 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 9.288826e-01 | 0.032 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 9.315335e-01 | 0.031 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.367626e-01 | 0.028 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.417120e-01 | 0.026 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.567236e-01 | 0.019 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 9.582256e-01 | 0.019 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.652099e-01 | 0.015 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 9.656350e-01 | 0.015 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.912815e-01 | 0.004 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 9.917421e-01 | 0.004 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 9.917778e-01 | 0.004 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 9.947124e-01 | 0.002 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.998172e-01 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.999275e-01 | 0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 9.999990e-01 | 0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | 0.000 | 0 | 0 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 1.110223e-16 | 15.955 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 3.985701e-14 | 13.399 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 7.693846e-14 | 13.114 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 1.079137e-13 | 12.967 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 9.781065e-14 | 13.010 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 8.193446e-14 | 13.087 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 1.900702e-13 | 12.721 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 1.707523e-13 | 12.768 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 2.954303e-13 | 12.530 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 5.875300e-13 | 12.231 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 6.664669e-13 | 12.176 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 9.922063e-13 | 12.003 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 1.333489e-12 | 11.875 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 1.529443e-12 | 11.815 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 2.681744e-12 | 11.572 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 2.436273e-12 | 11.613 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 3.438916e-12 | 11.464 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 4.091949e-12 | 11.388 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 2.565725e-11 | 10.591 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 4.363987e-11 | 10.360 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 1.145593e-10 | 9.941 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 1.145593e-10 | 9.941 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 1.138838e-10 | 9.944 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 1.251005e-10 | 9.903 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 1.505309e-10 | 9.822 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 1.501490e-10 | 9.823 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 2.488991e-10 | 9.604 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 4.008538e-10 | 9.397 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 5.141154e-10 | 9.289 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 6.303809e-10 | 9.200 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 8.030726e-10 | 9.095 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 3.336531e-09 | 8.477 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 4.113135e-09 | 8.386 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 6.414949e-09 | 8.193 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 8.951657e-09 | 8.048 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 9.105346e-09 | 8.041 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 1.057106e-08 | 7.976 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 1.207300e-08 | 7.918 | 0 | 0 |
| Protein folding | R-HSA-391251 | 2.327564e-08 | 7.633 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 2.757270e-08 | 7.560 | 0 | 0 |
| Kinesins | R-HSA-983189 | 4.594457e-08 | 7.338 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 5.136550e-08 | 7.289 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 4.946400e-08 | 7.306 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 6.983539e-08 | 7.156 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 1.030320e-07 | 6.987 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 1.172059e-07 | 6.931 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 1.443548e-07 | 6.841 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 1.808217e-07 | 6.743 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 1.957777e-07 | 6.708 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 2.127238e-07 | 6.672 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 2.211495e-07 | 6.655 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 2.980971e-07 | 6.526 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 4.550536e-07 | 6.342 | 0 | 0 |
| Immune System | R-HSA-168256 | 5.224444e-07 | 6.282 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 5.763382e-07 | 6.239 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 1.176024e-06 | 5.930 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 1.287073e-06 | 5.890 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 1.287073e-06 | 5.890 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 1.407678e-06 | 5.851 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 1.685784e-06 | 5.773 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 2.407645e-06 | 5.618 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 2.491368e-06 | 5.604 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 2.704051e-06 | 5.568 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 5.376501e-06 | 5.270 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 5.598334e-06 | 5.252 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 5.869683e-06 | 5.231 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 7.223914e-06 | 5.141 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 8.974787e-06 | 5.047 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 1.325420e-05 | 4.878 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 1.355348e-05 | 4.868 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 1.385337e-05 | 4.858 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 1.607527e-05 | 4.794 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 1.630144e-05 | 4.788 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 1.816890e-05 | 4.741 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 2.680044e-05 | 4.572 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 2.700760e-05 | 4.569 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 3.271472e-05 | 4.485 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 3.605119e-05 | 4.443 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 3.966224e-05 | 4.402 | 0 | 0 |
| M Phase | R-HSA-68886 | 4.497010e-05 | 4.347 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 4.708264e-05 | 4.327 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 4.970270e-05 | 4.304 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 5.515646e-05 | 4.258 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 5.603264e-05 | 4.252 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 6.101914e-05 | 4.215 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 6.246084e-05 | 4.204 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 6.246084e-05 | 4.204 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 6.530228e-05 | 4.185 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 7.152595e-05 | 4.146 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 6.622139e-05 | 4.179 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 7.783681e-05 | 4.109 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 8.064338e-05 | 4.093 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 8.484329e-05 | 4.071 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 9.018759e-05 | 4.045 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 9.603057e-05 | 4.018 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 9.603057e-05 | 4.018 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 1.105973e-04 | 3.956 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 1.105973e-04 | 3.956 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 1.105973e-04 | 3.956 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 1.105973e-04 | 3.956 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 1.105973e-04 | 3.956 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 1.401890e-04 | 3.853 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 1.476346e-04 | 3.831 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 1.625138e-04 | 3.789 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 1.625138e-04 | 3.789 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 1.625470e-04 | 3.789 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 1.660875e-04 | 3.780 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 2.361347e-04 | 3.627 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 2.570773e-04 | 3.590 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 2.754261e-04 | 3.560 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 3.038700e-04 | 3.517 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 3.016474e-04 | 3.521 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 2.771604e-04 | 3.557 | 1 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 3.111476e-04 | 3.507 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 3.142446e-04 | 3.503 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 3.604676e-04 | 3.443 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 3.789795e-04 | 3.421 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 3.816092e-04 | 3.418 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 4.418605e-04 | 3.355 | 0 | 0 |
| Disease | R-HSA-1643685 | 4.625889e-04 | 3.335 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 4.654879e-04 | 3.332 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 4.795698e-04 | 3.319 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 4.860262e-04 | 3.313 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 4.929154e-04 | 3.307 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 4.929154e-04 | 3.307 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 5.457033e-04 | 3.263 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 6.335788e-04 | 3.198 | 0 | 0 |
| Manipulation of host energy metabolism | R-HSA-9636667 | 8.065171e-04 | 3.093 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 7.654617e-04 | 3.116 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 8.742411e-04 | 3.058 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 9.511649e-04 | 3.022 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 1.018226e-03 | 2.992 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 1.114413e-03 | 2.953 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 1.158714e-03 | 2.936 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 1.184438e-03 | 2.926 | 1 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 1.362099e-03 | 2.866 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 1.410654e-03 | 2.851 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 1.410654e-03 | 2.851 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 1.410654e-03 | 2.851 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 1.435639e-03 | 2.843 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 1.443096e-03 | 2.841 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 1.597479e-03 | 2.797 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 1.866931e-03 | 2.729 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 2.014229e-03 | 2.696 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 2.538136e-03 | 2.595 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 2.206487e-03 | 2.656 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 2.122076e-03 | 2.673 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 2.206487e-03 | 2.656 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 2.345495e-03 | 2.630 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 2.345495e-03 | 2.630 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 2.328330e-03 | 2.633 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 2.642042e-03 | 2.578 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 2.708625e-03 | 2.567 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 2.940553e-03 | 2.532 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 3.261886e-03 | 2.487 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 3.262278e-03 | 2.486 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 3.413834e-03 | 2.467 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 3.441415e-03 | 2.463 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 3.531897e-03 | 2.452 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 4.761611e-03 | 2.322 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 5.034403e-03 | 2.298 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 5.108668e-03 | 2.292 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 5.155136e-03 | 2.288 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 5.155136e-03 | 2.288 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 5.484779e-03 | 2.261 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 5.904775e-03 | 2.229 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 6.143225e-03 | 2.212 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 6.143225e-03 | 2.212 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 6.250548e-03 | 2.204 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 6.250548e-03 | 2.204 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 6.665860e-03 | 2.176 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 6.866226e-03 | 2.163 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 6.902801e-03 | 2.161 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 7.570039e-03 | 2.121 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 8.397178e-03 | 2.076 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 9.046309e-03 | 2.044 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 8.418839e-03 | 2.075 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 8.418839e-03 | 2.075 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 8.214699e-03 | 2.085 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 9.817318e-03 | 2.008 | 0 | 0 |
| Interleukin-23 signaling | R-HSA-9020933 | 1.009672e-02 | 1.996 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 1.069969e-02 | 1.971 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 1.185179e-02 | 1.926 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 1.190981e-02 | 1.924 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 1.190981e-02 | 1.924 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 1.200218e-02 | 1.921 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 1.228046e-02 | 1.911 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 1.251665e-02 | 1.903 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 1.261273e-02 | 1.899 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 1.385417e-02 | 1.858 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 1.385417e-02 | 1.858 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 1.385417e-02 | 1.858 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 1.449959e-02 | 1.839 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 1.459562e-02 | 1.836 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 1.520314e-02 | 1.818 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 1.592597e-02 | 1.798 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 1.626869e-02 | 1.789 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 1.706962e-02 | 1.768 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 1.994445e-02 | 1.700 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 2.019376e-02 | 1.695 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 2.043687e-02 | 1.690 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 2.043687e-02 | 1.690 | 0 | 0 |
| Defective EXT2 causes exostoses 2 | R-HSA-3656237 | 2.043687e-02 | 1.690 | 0 | 0 |
| Defective EXT1 causes exostoses 1, TRPS2 and CHDS | R-HSA-3656253 | 2.043687e-02 | 1.690 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 2.081353e-02 | 1.682 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 2.119817e-02 | 1.674 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 2.129634e-02 | 1.672 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 2.145989e-02 | 1.668 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 2.145989e-02 | 1.668 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 2.145989e-02 | 1.668 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 2.200237e-02 | 1.658 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 2.806734e-02 | 1.552 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 2.541333e-02 | 1.595 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 2.694991e-02 | 1.569 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 2.375745e-02 | 1.624 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 2.842860e-02 | 1.546 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 2.842860e-02 | 1.546 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 2.452065e-02 | 1.610 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 2.860263e-02 | 1.544 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 2.670214e-02 | 1.573 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 2.986142e-02 | 1.525 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 2.551363e-02 | 1.593 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 2.990661e-02 | 1.524 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 3.081718e-02 | 1.511 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 3.082734e-02 | 1.511 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 3.084737e-02 | 1.511 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 3.151280e-02 | 1.502 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 3.151280e-02 | 1.502 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 3.191372e-02 | 1.496 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 3.306534e-02 | 1.481 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 3.328804e-02 | 1.478 | 0 | 0 |
| Defective B3GALT6 causes EDSP2 and SEMDJL1 | R-HSA-4420332 | 3.368999e-02 | 1.472 | 0 | 0 |
| Defective B4GALT7 causes EDS, progeroid type | R-HSA-3560783 | 3.368999e-02 | 1.472 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 3.476518e-02 | 1.459 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 3.665205e-02 | 1.436 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 3.665205e-02 | 1.436 | 0 | 0 |
| Defective B3GAT3 causes JDSSDHD | R-HSA-3560801 | 3.665205e-02 | 1.436 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 3.665205e-02 | 1.436 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 3.818438e-02 | 1.418 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 3.971035e-02 | 1.401 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 3.971035e-02 | 1.401 | 0 | 0 |
| Defective SLC4A1 causes hereditary spherocytosis type 4 (HSP4), distal renal tubular acidosis (dRTA) and dRTA with hemolytic anemia (dRTA-HA) | R-HSA-5619050 | 3.998239e-02 | 1.398 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 | R-HSA-9630794 | 3.998239e-02 | 1.398 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 | R-HSA-9632700 | 3.998239e-02 | 1.398 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to p16INK4A Defects | R-HSA-9632693 | 3.998239e-02 | 1.398 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to p16INK4A Defects | R-HSA-9630750 | 3.998239e-02 | 1.398 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 4.176869e-02 | 1.379 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 4.286175e-02 | 1.368 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 4.286175e-02 | 1.368 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 4.314653e-02 | 1.365 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 5.295300e-02 | 1.276 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 5.295300e-02 | 1.276 | 0 | 0 |
| Defective AHCY causes HMAHCHD | R-HSA-5578997 | 5.295300e-02 | 1.276 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 5.295300e-02 | 1.276 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 5.295300e-02 | 1.276 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 5.295300e-02 | 1.276 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 5.295300e-02 | 1.276 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 5.295300e-02 | 1.276 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 5.295300e-02 | 1.276 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 5.295300e-02 | 1.276 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 5.295300e-02 | 1.276 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 5.295300e-02 | 1.276 | 0 | 0 |
| Axonal growth stimulation | R-HSA-209563 | 6.574916e-02 | 1.182 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 6.574916e-02 | 1.182 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 4.943178e-02 | 1.306 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 4.943178e-02 | 1.306 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 5.284450e-02 | 1.277 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 5.284450e-02 | 1.277 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 5.284450e-02 | 1.277 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 5.633852e-02 | 1.249 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 5.633852e-02 | 1.249 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 6.355934e-02 | 1.197 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 5.633852e-02 | 1.249 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 6.519523e-02 | 1.186 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 6.473774e-02 | 1.189 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 6.473774e-02 | 1.189 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 6.473774e-02 | 1.189 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 5.143833e-02 | 1.289 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 5.295300e-02 | 1.276 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 6.574916e-02 | 1.182 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 5.323535e-02 | 1.274 | 0 | 0 |
| Attachment and Entry | R-HSA-9694614 | 5.284450e-02 | 1.277 | 0 | 0 |
| Diseases of Cellular Senescence | R-HSA-9630747 | 5.295300e-02 | 1.276 | 0 | 0 |
| Diseases of cellular response to stress | R-HSA-9675132 | 5.295300e-02 | 1.276 | 0 | 0 |
| Translation | R-HSA-72766 | 4.533844e-02 | 1.344 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 5.771405e-02 | 1.239 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 5.515789e-02 | 1.258 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 5.515789e-02 | 1.258 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 6.337024e-02 | 1.198 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 4.610323e-02 | 1.336 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 4.943178e-02 | 1.306 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 5.991105e-02 | 1.222 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 4.610323e-02 | 1.336 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 5.934302e-02 | 1.227 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 6.116013e-02 | 1.214 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 5.082154e-02 | 1.294 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 4.942455e-02 | 1.306 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 6.661498e-02 | 1.176 | 1 | 0 |
| Long-term potentiation | R-HSA-9620244 | 6.728073e-02 | 1.172 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 6.728073e-02 | 1.172 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 6.728073e-02 | 1.172 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 6.728073e-02 | 1.172 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 6.895881e-02 | 1.161 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 7.107260e-02 | 1.148 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 7.107260e-02 | 1.148 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 7.180638e-02 | 1.144 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 7.324167e-02 | 1.135 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 7.367693e-02 | 1.133 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 7.493237e-02 | 1.125 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 7.493237e-02 | 1.125 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 7.837320e-02 | 1.106 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 7.837320e-02 | 1.106 | 0 | 0 |
| Drug-mediated inhibition of CDK4/CDK6 activity | R-HSA-9754119 | 7.837320e-02 | 1.106 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 7.885755e-02 | 1.103 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 8.254240e-02 | 1.083 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 8.284568e-02 | 1.082 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 8.284568e-02 | 1.082 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 8.689437e-02 | 1.061 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 8.689437e-02 | 1.061 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 8.689437e-02 | 1.061 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 8.689437e-02 | 1.061 | 0 | 0 |
| IRS activation | R-HSA-74713 | 9.082742e-02 | 1.042 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 9.082742e-02 | 1.042 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 9.082742e-02 | 1.042 | 0 | 0 |
| Co-inhibition by BTLA | R-HSA-9927353 | 9.082742e-02 | 1.042 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 9.100126e-02 | 1.041 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 9.100126e-02 | 1.041 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 9.516406e-02 | 1.022 | 0 | 0 |
| HS-GAG degradation | R-HSA-2024096 | 9.516406e-02 | 1.022 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 9.672431e-02 | 1.014 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 9.938054e-02 | 1.003 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 9.938054e-02 | 1.003 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 9.938054e-02 | 1.003 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 1.022013e-01 | 0.991 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 1.031141e-01 | 0.987 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 1.031141e-01 | 0.987 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 1.031141e-01 | 0.987 | 0 | 0 |
| Cam-PDE 1 activation | R-HSA-111957 | 1.031141e-01 | 0.987 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 1.031141e-01 | 0.987 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 1.152355e-01 | 0.938 | 0 | 0 |
| MET activates PI3K/AKT signaling | R-HSA-8851907 | 1.271938e-01 | 0.896 | 0 | 0 |
| TRIF-mediated programmed cell death | R-HSA-2562578 | 1.271938e-01 | 0.896 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 1.271938e-01 | 0.896 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 1.271938e-01 | 0.896 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 1.389912e-01 | 0.857 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 1.389912e-01 | 0.857 | 0 | 0 |
| Activated NTRK2 signals through PI3K | R-HSA-9028335 | 1.389912e-01 | 0.857 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 1.506299e-01 | 0.822 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 1.621119e-01 | 0.790 | 0 | 0 |
| Activation of Ca-permeable Kainate Receptor | R-HSA-451308 | 1.621119e-01 | 0.790 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 1.621119e-01 | 0.790 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 1.846145e-01 | 0.734 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 2.065155e-01 | 0.685 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 1.036485e-01 | 0.984 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 1.079658e-01 | 0.967 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 1.676879e-01 | 0.775 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 1.968448e-01 | 0.706 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 2.017663e-01 | 0.695 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 1.596853e-01 | 0.797 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 1.761863e-01 | 0.754 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 1.863064e-01 | 0.730 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 1.172445e-01 | 0.931 | 0 | 0 |
| HS-GAG biosynthesis | R-HSA-2022928 | 1.167400e-01 | 0.933 | 0 | 0 |
| Glycosaminoglycan-protein linkage region biosynthesis | R-HSA-1971475 | 1.079658e-01 | 0.967 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 1.506299e-01 | 0.822 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 1.389912e-01 | 0.857 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 1.621119e-01 | 0.790 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 1.621119e-01 | 0.790 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 1.734395e-01 | 0.761 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 1.036485e-01 | 0.984 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 1.468504e-01 | 0.833 | 0 | 0 |
| Microbial factors inhibit CASP4 activity | R-HSA-9956593 | 2.065155e-01 | 0.685 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 1.931363e-01 | 0.714 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 2.065155e-01 | 0.685 | 0 | 0 |
| PTK6 Expression | R-HSA-8849473 | 1.271938e-01 | 0.896 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 1.389912e-01 | 0.857 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 1.506299e-01 | 0.822 | 0 | 0 |
| IL-6-type cytokine receptor ligand interactions | R-HSA-6788467 | 2.065155e-01 | 0.685 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 1.506299e-01 | 0.822 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 1.621119e-01 | 0.790 | 0 | 0 |
| Ionotropic activity of kainate receptors | R-HSA-451306 | 1.734395e-01 | 0.761 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 1.734395e-01 | 0.761 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 1.846145e-01 | 0.734 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 1.956392e-01 | 0.709 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 1.956392e-01 | 0.709 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 2.065155e-01 | 0.685 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 2.065155e-01 | 0.685 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 1.167400e-01 | 0.933 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 1.079658e-01 | 0.967 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 1.313211e-01 | 0.882 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 1.956392e-01 | 0.709 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 1.621119e-01 | 0.790 | 0 | 0 |
| Interleukin-27 signaling | R-HSA-9020956 | 1.621119e-01 | 0.790 | 0 | 0 |
| Chylomicron assembly | R-HSA-8963888 | 1.734395e-01 | 0.761 | 0 | 0 |
| Diseases associated with glycosaminoglycan metabolism | R-HSA-3560782 | 1.629037e-01 | 0.788 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 1.256870e-01 | 0.901 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 1.440382e-01 | 0.842 | 0 | 0 |
| LDL remodeling | R-HSA-8964041 | 1.271938e-01 | 0.896 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 1.389912e-01 | 0.857 | 0 | 0 |
| Regulation of signaling by NODAL | R-HSA-1433617 | 1.506299e-01 | 0.822 | 0 | 0 |
| MAPK1 (ERK2) activation | R-HSA-112411 | 1.506299e-01 | 0.822 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 1.621119e-01 | 0.790 | 0 | 0 |
| Reduction of cytosolic Ca++ levels | R-HSA-418359 | 1.846145e-01 | 0.734 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 2.065155e-01 | 0.685 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 1.621119e-01 | 0.790 | 0 | 0 |
| CASP4 inflammasome assembly | R-HSA-9948001 | 1.621119e-01 | 0.790 | 0 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 1.271938e-01 | 0.896 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 1.621119e-01 | 0.790 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 1.734395e-01 | 0.761 | 0 | 0 |
| Sodium/Calcium exchangers | R-HSA-425561 | 1.846145e-01 | 0.734 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 1.956392e-01 | 0.709 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 1.211929e-01 | 0.917 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 1.302205e-01 | 0.885 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 1.049854e-01 | 0.979 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 1.167400e-01 | 0.933 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 1.193412e-01 | 0.923 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 1.506299e-01 | 0.822 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 1.167400e-01 | 0.933 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 1.863064e-01 | 0.730 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 1.152355e-01 | 0.938 | 0 | 0 |
| VLDL assembly | R-HSA-8866423 | 1.152355e-01 | 0.938 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 1.956392e-01 | 0.709 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 1.956392e-01 | 0.709 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 1.956392e-01 | 0.709 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 1.795423e-01 | 0.746 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 1.256870e-01 | 0.901 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 1.506299e-01 | 0.822 | 0 | 0 |
| Erythrocytes take up oxygen and release carbon dioxide | R-HSA-1247673 | 1.956392e-01 | 0.709 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 2.065155e-01 | 0.685 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 1.870494e-01 | 0.728 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 2.067019e-01 | 0.685 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 1.123303e-01 | 0.950 | 0 | 0 |
| Interleukin-35 Signalling | R-HSA-8984722 | 1.956392e-01 | 0.709 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 2.065155e-01 | 0.685 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 1.506299e-01 | 0.822 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 1.621119e-01 | 0.790 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 1.870494e-01 | 0.728 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 1.995697e-01 | 0.700 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 1.965747e-01 | 0.706 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 2.065155e-01 | 0.685 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 1.621119e-01 | 0.790 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 1.487106e-01 | 0.828 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 1.629037e-01 | 0.788 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 1.256870e-01 | 0.901 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 1.348171e-01 | 0.870 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 1.079658e-01 | 0.967 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 1.913122e-01 | 0.718 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 1.534135e-01 | 0.814 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 2.067123e-01 | 0.685 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 1.534135e-01 | 0.814 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 1.534135e-01 | 0.814 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 2.069779e-01 | 0.684 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 2.107438e-01 | 0.676 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 2.139819e-01 | 0.670 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 2.166105e-01 | 0.664 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 2.166105e-01 | 0.664 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 2.172454e-01 | 0.663 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 2.172454e-01 | 0.663 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 2.172454e-01 | 0.663 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 2.172454e-01 | 0.663 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 2.172454e-01 | 0.663 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 2.172454e-01 | 0.663 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 2.172454e-01 | 0.663 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 2.172454e-01 | 0.663 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 2.172454e-01 | 0.663 | 0 | 0 |
| Non-canonical inflammasome activation | R-HSA-9686114 | 2.172454e-01 | 0.663 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 2.192389e-01 | 0.659 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 2.215810e-01 | 0.654 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 2.220911e-01 | 0.653 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 2.249532e-01 | 0.648 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 2.265608e-01 | 0.645 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 2.265608e-01 | 0.645 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 2.278308e-01 | 0.642 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 2.278308e-01 | 0.642 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 2.278308e-01 | 0.642 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 2.278308e-01 | 0.642 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 2.278308e-01 | 0.642 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 2.278308e-01 | 0.642 | 0 | 0 |
| Other semaphorin interactions | R-HSA-416700 | 2.278308e-01 | 0.642 | 0 | 0 |
| Heparan sulfate/heparin (HS-GAG) metabolism | R-HSA-1638091 | 2.315486e-01 | 0.635 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 2.315486e-01 | 0.635 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 2.317041e-01 | 0.635 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 2.382738e-01 | 0.623 | 0 | 0 |
| Entry of Influenza Virion into Host Cell via Endocytosis | R-HSA-168275 | 2.382738e-01 | 0.623 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 2.382738e-01 | 0.623 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 2.382738e-01 | 0.623 | 0 | 0 |
| Caspase activation via Death Receptors in the presence of ligand | R-HSA-140534 | 2.382738e-01 | 0.623 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 2.382738e-01 | 0.623 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 2.388681e-01 | 0.622 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 2.388681e-01 | 0.622 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 2.415441e-01 | 0.617 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 2.415441e-01 | 0.617 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 2.465495e-01 | 0.608 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 2.465495e-01 | 0.608 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 2.485761e-01 | 0.605 | 0 | 0 |
| Fibronectin matrix formation | R-HSA-1566977 | 2.485761e-01 | 0.605 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 2.485761e-01 | 0.605 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 2.485761e-01 | 0.605 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 2.485761e-01 | 0.605 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 2.496834e-01 | 0.603 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 2.515587e-01 | 0.599 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 2.515587e-01 | 0.599 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 2.565707e-01 | 0.591 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 2.565707e-01 | 0.591 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 2.565707e-01 | 0.591 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 2.565707e-01 | 0.591 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 2.569346e-01 | 0.590 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 2.569346e-01 | 0.590 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 2.587397e-01 | 0.587 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 2.587397e-01 | 0.587 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 2.587397e-01 | 0.587 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 2.615844e-01 | 0.582 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 2.615844e-01 | 0.582 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 2.674767e-01 | 0.573 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 2.687665e-01 | 0.571 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 2.687665e-01 | 0.571 | 0 | 0 |
| PKA activation | R-HSA-163615 | 2.687665e-01 | 0.571 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 2.687665e-01 | 0.571 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 2.687665e-01 | 0.571 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 2.728728e-01 | 0.564 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 2.786583e-01 | 0.555 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 2.786583e-01 | 0.555 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 2.786583e-01 | 0.555 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 2.786583e-01 | 0.555 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 2.786583e-01 | 0.555 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 2.786583e-01 | 0.555 | 0 | 0 |
| Strand-asynchronous mitochondrial DNA replication | R-HSA-9913635 | 2.786583e-01 | 0.555 | 0 | 0 |
| O2/CO2 exchange in erythrocytes | R-HSA-1480926 | 2.786583e-01 | 0.555 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 2.786583e-01 | 0.555 | 0 | 0 |
| Erythrocytes take up carbon dioxide and release oxygen | R-HSA-1237044 | 2.786583e-01 | 0.555 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 2.786583e-01 | 0.555 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 2.788477e-01 | 0.555 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 2.788477e-01 | 0.555 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 2.816383e-01 | 0.550 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 2.861942e-01 | 0.543 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 2.866470e-01 | 0.543 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 2.884168e-01 | 0.540 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 2.884168e-01 | 0.540 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 2.884168e-01 | 0.540 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 2.916521e-01 | 0.535 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 2.916521e-01 | 0.535 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 2.916521e-01 | 0.535 | 0 | 0 |
| Retinoid metabolism and transport | R-HSA-975634 | 2.916521e-01 | 0.535 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 2.916521e-01 | 0.535 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 2.980439e-01 | 0.526 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 2.980439e-01 | 0.526 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 2.980439e-01 | 0.526 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 2.980439e-01 | 0.526 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 3.009314e-01 | 0.522 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 3.016483e-01 | 0.520 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 3.066377e-01 | 0.513 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 3.066377e-01 | 0.513 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 3.075414e-01 | 0.512 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 3.075414e-01 | 0.512 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 3.075414e-01 | 0.512 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 3.075414e-01 | 0.512 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 3.083159e-01 | 0.511 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 3.116205e-01 | 0.506 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 3.116205e-01 | 0.506 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 3.169110e-01 | 0.499 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 3.169110e-01 | 0.499 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 3.169110e-01 | 0.499 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 3.169110e-01 | 0.499 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 3.169110e-01 | 0.499 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 3.231022e-01 | 0.491 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 3.261543e-01 | 0.487 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 3.261543e-01 | 0.487 | 0 | 0 |
| Interleukin-20 family signaling | R-HSA-8854691 | 3.261543e-01 | 0.487 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 3.261543e-01 | 0.487 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 3.261543e-01 | 0.487 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 3.261543e-01 | 0.487 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 3.261543e-01 | 0.487 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 3.261543e-01 | 0.487 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 3.265213e-01 | 0.486 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 3.272376e-01 | 0.485 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 3.352731e-01 | 0.475 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 3.352731e-01 | 0.475 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 3.352731e-01 | 0.475 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 3.352731e-01 | 0.475 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 3.352731e-01 | 0.475 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 3.364087e-01 | 0.473 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 3.364087e-01 | 0.473 | 0 | 0 |
| Metabolism of fat-soluble vitamins | R-HSA-6806667 | 3.413366e-01 | 0.467 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 3.442691e-01 | 0.463 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 3.442691e-01 | 0.463 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 3.442691e-01 | 0.463 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 3.442691e-01 | 0.463 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 3.442691e-01 | 0.463 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 3.442691e-01 | 0.463 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 3.442691e-01 | 0.463 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 3.452825e-01 | 0.462 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 3.462531e-01 | 0.461 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 3.531439e-01 | 0.452 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 3.531439e-01 | 0.452 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 3.531439e-01 | 0.452 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 3.547578e-01 | 0.450 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 3.560495e-01 | 0.448 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 3.563537e-01 | 0.448 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 3.618991e-01 | 0.441 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 3.618991e-01 | 0.441 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 3.618991e-01 | 0.441 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 3.618991e-01 | 0.441 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 3.618991e-01 | 0.441 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 3.618991e-01 | 0.441 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 3.618991e-01 | 0.441 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 3.657935e-01 | 0.437 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 3.657935e-01 | 0.437 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 3.704013e-01 | 0.431 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 3.705363e-01 | 0.431 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 3.705363e-01 | 0.431 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 3.705363e-01 | 0.431 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 3.705363e-01 | 0.431 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 3.705363e-01 | 0.431 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 3.705363e-01 | 0.431 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 3.705363e-01 | 0.431 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 3.705363e-01 | 0.431 | 0 | 0 |
| Iron assimilation using enterobactin | R-HSA-9638334 | 3.705363e-01 | 0.431 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 3.706445e-01 | 0.431 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 3.706445e-01 | 0.431 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 3.790572e-01 | 0.421 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 3.790572e-01 | 0.421 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 3.790572e-01 | 0.421 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 3.790572e-01 | 0.421 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 3.790572e-01 | 0.421 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 3.790572e-01 | 0.421 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 3.851075e-01 | 0.414 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 3.874632e-01 | 0.412 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 3.874632e-01 | 0.412 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 3.874632e-01 | 0.412 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 3.874632e-01 | 0.412 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 3.874632e-01 | 0.412 | 1 | 1 |
| Visual phototransduction | R-HSA-2187338 | 3.893914e-01 | 0.410 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 3.946699e-01 | 0.404 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 3.946699e-01 | 0.404 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 3.957560e-01 | 0.403 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 3.957560e-01 | 0.403 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 3.994258e-01 | 0.399 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 4.003198e-01 | 0.398 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 4.041644e-01 | 0.393 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 4.041644e-01 | 0.393 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 4.075759e-01 | 0.390 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 4.075759e-01 | 0.390 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 4.120077e-01 | 0.385 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 4.120077e-01 | 0.385 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 4.120077e-01 | 0.385 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 4.120077e-01 | 0.385 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 4.135879e-01 | 0.383 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 4.135879e-01 | 0.383 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 4.182720e-01 | 0.379 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 4.182720e-01 | 0.379 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 4.199696e-01 | 0.377 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 4.199696e-01 | 0.377 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 4.229373e-01 | 0.374 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 4.278242e-01 | 0.369 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 4.278242e-01 | 0.369 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 4.278242e-01 | 0.369 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 4.278242e-01 | 0.369 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 4.278242e-01 | 0.369 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 4.278242e-01 | 0.369 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 4.278242e-01 | 0.369 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 4.291808e-01 | 0.367 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 4.322097e-01 | 0.364 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 4.355729e-01 | 0.361 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 4.355729e-01 | 0.361 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 4.355729e-01 | 0.361 | 0 | 0 |
| Metabolism of ingested SeMet, Sec, MeSec into H2Se | R-HSA-2408508 | 4.355729e-01 | 0.361 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 4.355729e-01 | 0.361 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 4.414026e-01 | 0.355 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 4.432172e-01 | 0.353 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 4.432172e-01 | 0.353 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 4.459685e-01 | 0.351 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 4.505029e-01 | 0.346 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 4.505136e-01 | 0.346 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 4.507584e-01 | 0.346 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 4.581979e-01 | 0.339 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 4.595404e-01 | 0.338 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 4.655371e-01 | 0.332 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 4.655371e-01 | 0.332 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 4.655371e-01 | 0.332 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 4.655371e-01 | 0.332 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 4.711928e-01 | 0.327 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 4.727773e-01 | 0.325 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 4.727773e-01 | 0.325 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 4.727773e-01 | 0.325 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 4.727773e-01 | 0.325 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 4.727773e-01 | 0.325 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 4.727773e-01 | 0.325 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 4.727773e-01 | 0.325 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 4.727773e-01 | 0.325 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 4.727773e-01 | 0.325 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 4.727773e-01 | 0.325 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 4.727773e-01 | 0.325 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 4.727773e-01 | 0.325 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 4.773334e-01 | 0.321 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 4.784170e-01 | 0.320 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 4.799199e-01 | 0.319 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 4.799199e-01 | 0.319 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 4.817261e-01 | 0.317 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 4.817261e-01 | 0.317 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 4.852938e-01 | 0.314 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 4.852938e-01 | 0.314 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 4.860961e-01 | 0.313 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 4.869662e-01 | 0.313 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 4.869662e-01 | 0.313 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 4.869662e-01 | 0.313 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 4.939174e-01 | 0.306 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 5.007749e-01 | 0.300 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 5.007749e-01 | 0.300 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 5.075398e-01 | 0.295 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 5.075398e-01 | 0.295 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 5.075398e-01 | 0.295 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 5.075398e-01 | 0.295 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 5.075398e-01 | 0.295 | 0 | 0 |
| Methylation | R-HSA-156581 | 5.075398e-01 | 0.295 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 5.090138e-01 | 0.293 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 5.142136e-01 | 0.289 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 5.142136e-01 | 0.289 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 5.142136e-01 | 0.289 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 5.142136e-01 | 0.289 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 5.142136e-01 | 0.289 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 5.207972e-01 | 0.283 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 5.207972e-01 | 0.283 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 5.207972e-01 | 0.283 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 5.207972e-01 | 0.283 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 5.207972e-01 | 0.283 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 5.239734e-01 | 0.281 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 5.243774e-01 | 0.280 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 5.272921e-01 | 0.278 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 5.336993e-01 | 0.273 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 5.336993e-01 | 0.273 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 5.336993e-01 | 0.273 | 0 | 0 |
| Plasma lipoprotein remodeling | R-HSA-8963899 | 5.336993e-01 | 0.273 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 5.367073e-01 | 0.270 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 5.400201e-01 | 0.268 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 5.400201e-01 | 0.268 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 5.400201e-01 | 0.268 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 5.462555e-01 | 0.263 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 5.488169e-01 | 0.261 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 5.514988e-01 | 0.258 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 5.524069e-01 | 0.258 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 5.524069e-01 | 0.258 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 5.567664e-01 | 0.254 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 5.584752e-01 | 0.253 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 5.584752e-01 | 0.253 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 5.607040e-01 | 0.251 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 5.607040e-01 | 0.251 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 5.644616e-01 | 0.248 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 5.644616e-01 | 0.248 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 5.644616e-01 | 0.248 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 5.644616e-01 | 0.248 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 5.644616e-01 | 0.248 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 5.703672e-01 | 0.244 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 5.761931e-01 | 0.239 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 5.761931e-01 | 0.239 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 5.761931e-01 | 0.239 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 5.761931e-01 | 0.239 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 5.761931e-01 | 0.239 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 5.819403e-01 | 0.235 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 5.819403e-01 | 0.235 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 5.819403e-01 | 0.235 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 5.819403e-01 | 0.235 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 5.826706e-01 | 0.235 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 5.826706e-01 | 0.235 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 5.875669e-01 | 0.231 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 5.876100e-01 | 0.231 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 5.876100e-01 | 0.231 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 5.891779e-01 | 0.230 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 5.987207e-01 | 0.223 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 5.987207e-01 | 0.223 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 5.987207e-01 | 0.223 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 5.987207e-01 | 0.223 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 5.987207e-01 | 0.223 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 6.041638e-01 | 0.219 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 6.095334e-01 | 0.215 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 6.148305e-01 | 0.211 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 6.148305e-01 | 0.211 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 6.148305e-01 | 0.211 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 6.200560e-01 | 0.208 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 6.238081e-01 | 0.205 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 6.252110e-01 | 0.204 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 6.402619e-01 | 0.194 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 6.402619e-01 | 0.194 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 6.451439e-01 | 0.190 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 6.451439e-01 | 0.190 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 6.451439e-01 | 0.190 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 6.516895e-01 | 0.186 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 6.543820e-01 | 0.184 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 6.547110e-01 | 0.184 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 6.547110e-01 | 0.184 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 6.593978e-01 | 0.181 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 6.593978e-01 | 0.181 | 0 | 0 |
| Metal ion assimilation from the host | R-HSA-9638482 | 6.593978e-01 | 0.181 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 6.597225e-01 | 0.181 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 6.640009e-01 | 0.178 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 6.640213e-01 | 0.178 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 6.685823e-01 | 0.175 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 6.685823e-01 | 0.175 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 6.730817e-01 | 0.172 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 6.734956e-01 | 0.172 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 6.766120e-01 | 0.170 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 6.797042e-01 | 0.168 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 6.818988e-01 | 0.166 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 6.818988e-01 | 0.166 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 6.827724e-01 | 0.166 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 6.880337e-01 | 0.162 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 6.888370e-01 | 0.162 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 6.904792e-01 | 0.161 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 6.904792e-01 | 0.161 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 6.904792e-01 | 0.161 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 6.904792e-01 | 0.161 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 6.937185e-01 | 0.159 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 6.946826e-01 | 0.158 | 0 | 0 |
| Metabolic disorders of biological oxidation enzymes | R-HSA-5579029 | 6.946826e-01 | 0.158 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 7.029197e-01 | 0.153 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 7.029197e-01 | 0.153 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 7.187361e-01 | 0.143 | 0 | 0 |
| Sulfur amino acid metabolism | R-HSA-1614635 | 7.263270e-01 | 0.139 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 7.409025e-01 | 0.130 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 7.409025e-01 | 0.130 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 7.547051e-01 | 0.122 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 7.547051e-01 | 0.122 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 7.580398e-01 | 0.120 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 7.611544e-01 | 0.119 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 7.641081e-01 | 0.117 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 7.677755e-01 | 0.115 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 7.677755e-01 | 0.115 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 7.682431e-01 | 0.115 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 7.740484e-01 | 0.111 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 7.757621e-01 | 0.110 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 7.771213e-01 | 0.110 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 7.831428e-01 | 0.106 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 7.860926e-01 | 0.105 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 7.860926e-01 | 0.105 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 7.918728e-01 | 0.101 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 7.947043e-01 | 0.100 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 7.947043e-01 | 0.100 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 7.996484e-01 | 0.097 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 8.029709e-01 | 0.095 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 8.056521e-01 | 0.094 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 8.056521e-01 | 0.094 | 0 | 0 |
| Infection with Enterobacteria | R-HSA-9640148 | 8.057613e-01 | 0.094 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 8.082970e-01 | 0.092 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 8.082970e-01 | 0.092 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 8.085955e-01 | 0.092 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 8.109060e-01 | 0.091 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 8.109060e-01 | 0.091 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 8.136547e-01 | 0.090 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 8.160186e-01 | 0.088 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 8.160186e-01 | 0.088 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 8.185230e-01 | 0.087 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 8.209935e-01 | 0.086 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 8.258345e-01 | 0.083 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 8.328527e-01 | 0.079 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 8.328527e-01 | 0.079 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 8.351290e-01 | 0.078 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 8.373744e-01 | 0.077 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 8.373744e-01 | 0.077 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 8.395893e-01 | 0.076 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 8.407688e-01 | 0.075 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 8.439296e-01 | 0.074 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 8.439296e-01 | 0.074 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 8.470533e-01 | 0.072 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 8.562613e-01 | 0.067 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 8.613330e-01 | 0.065 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 8.639386e-01 | 0.064 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 8.657932e-01 | 0.063 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 8.764044e-01 | 0.057 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 8.820347e-01 | 0.055 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 8.877329e-01 | 0.052 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 8.906882e-01 | 0.050 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 8.937358e-01 | 0.049 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 8.966164e-01 | 0.047 | 0 | 0 |
| S Phase | R-HSA-69242 | 8.966164e-01 | 0.047 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 8.994192e-01 | 0.046 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 8.998576e-01 | 0.046 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 9.034822e-01 | 0.044 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 9.034822e-01 | 0.044 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 9.086464e-01 | 0.042 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 9.203852e-01 | 0.036 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.250262e-01 | 0.034 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.256786e-01 | 0.034 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 9.290452e-01 | 0.032 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.395469e-01 | 0.027 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 9.435712e-01 | 0.025 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 9.444315e-01 | 0.025 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 9.589078e-01 | 0.018 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.615858e-01 | 0.017 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 9.616479e-01 | 0.017 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.655352e-01 | 0.015 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.700899e-01 | 0.013 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 9.713047e-01 | 0.013 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.743093e-01 | 0.011 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 9.770007e-01 | 0.010 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 9.800146e-01 | 0.009 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.813413e-01 | 0.008 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 9.832734e-01 | 0.007 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 9.840052e-01 | 0.007 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 9.888436e-01 | 0.005 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 9.904889e-01 | 0.004 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.911654e-01 | 0.004 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 9.928413e-01 | 0.003 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 9.953359e-01 | 0.002 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 9.967137e-01 | 0.001 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 9.985962e-01 | 0.001 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 9.997876e-01 | 0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | 0.000 | 0 | 0 |